Benign neoplasm: Colon

CD2_BENIGN_COLON

colonic neoplasm: A benign or malignant neoplasm that affects the colon. Representative examples of benign neoplasms include lipoma and leiomyoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and sarcoma. Colonic adenomas always exhibit epithelial dysplasia and are considered premalignant neoplasms.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints CD2_BENIGN_CAECUM CD2_BENIGN_APPENDIX CD2_BENIGN_ASCENDING_COLON CD2_BENIGN_TRANSVERSE_COLON CD2_BENIGN_DESCENDING_COLON CD2_BENIGN_SIGMOID_COLON CD2_BENIGN_COLON_NOS	24348
6. Filter based on genotype QC (FinnGen only)	24348

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	CD2_BENIGN_COLON
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	CD2_BENIGN_CAECUM\|CD2_BENIGN_APPENDIX\|CD2_BENIGN_ASCENDING_COLON\|CD2_BENIGN_TRANSVERSE_COLON\|CD2_BENIGN_DESCENDING_COLON\|CD2_BENIGN_SIGMOID_COLON\|CD2_BENIGN_COLON_NOS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Colon based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	132400	65346	66373
Only index persons	122287	61626	60661
Unadjusted period prevalence (%)
Whole population	1.86	1.87	1.85
Only index persons	2.29	2.27	2.32
Median age at first event (years)
Whole population	66.72	66.73	66.70
Only index persons	66.32	66.30	66.33

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	24348	11887	12461
Unadjusted period prevalence (%)	4.79	4.05	5.49
Median age at first event (years)	66.00	64.73	67.21

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
21177: Matched controls
208323

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.2

323.0

2162

7187

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

204.5

323.0

4244

255

UJF32

NOMESCO Finland

Coloscopy

15.1

323.0

15421

31299

N02BE01

ATC

paracetamol; systemic, rectal

2.1

323.0

18282

155955

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

323.0

8156

45636

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

279.2

323.0

6322

317

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

5.0

323.0

3658

8376

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

5.2

323.0

8119

22116

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

51.9

323.0

6502

1761

A02BC02

ATC

pantoprazole; systemic

2.0

323.0

14453

109075

UJF30

NOMESCO Finland

Ileoscopy through colon

6.7

323.0

4707

8538

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

725.0

323.0

8767

207

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

182.7

323.0

3164

200

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.5

323.0

9626

40299

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

10.9

323.0

2664

2723

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

23.7

323.0

1643

737

A06AC01

ATC

ispaghula (psylla seeds); oral

2.4

323.0

6555

33290

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

3.4

323.0

2565

8187

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

165.7

323.0

2055

135

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

323.0

10313

71203

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

202.6

323.0

3232

185

D64.9

ICD-10 Finland

Anaemia, unspecified

2.5

323.0

2899

12307

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

3.4

323.0

1795

5479

D12.1

ICD-10 Finland

Benign neoplasm: Appendix

1618.7

321.2

314

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

318.4

4970

27516

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.5

316.8

2899

12555

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

287.9

4007

21048

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

10.8

280.2

561

524

P01AB01

ATC

metronidazole; oral, rectal

1.7

270.8

8010

54506

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

7.1

266.4

687

980

JFA42

NOMESCO Finland

Endoscopic injection in colon

43.9

265.7

334

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

3.2

260.8

1496

4819

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

260.0

2742

12661

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.6

259.8

2126

8595

K92.1

ICD-10 Finland

Melaena

3.1

258.9

1566

5236

WX002

NOMESCO Finland

Sedation and analgesia

1.9

256.9

4696

27236

B01AB05

ATC

enoxaparin; parenteral

1.7

255.3

6973

46108

J01DB01

ATC

cefalexin; oral

1.8

252.1

16592

140164

A02BC05

ATC

esomeprazole; systemic

1.7

251.9

8604

60630

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

7.9

246.4

588

746

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

19.6

241.5

375

191

N02AX02

ATC

tramadol; systemic, rectal

1.6

228.0

9071

66000

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

225.0

2521

11916

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

222.6

4655

28055

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

213.6

3009

15675

UJH02

NOMESCO Finland

Anoscopy

3.3

212.8

1169

3633

A02BC03

ATC

lansoprazole; oral

1.7

212.3

6437

43297

JFA52

NOMESCO Finland

Other endoscopic haemostatic procedure in colon

40.7

211.8

270

K63.5

ICD-10 Finland

Polyp of colon

6.9

204.0

532

770

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

199.6

5948

39663

R06.0

ICD-10 Finland

Dyspnoea

1.7

199.3

5443

35406

H02AB06

ATC

prednisolone; systemic

1.6

198.5

9637

72760

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

194.5

5650

37346

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

14.4

191.7

334

231

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.8

181.2

1268

4634

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

171.6

3246

18706

R4110

NOMESCO Finland

Physiotherapy

1.6

169.1

5520

37371

R03AC02

ATC

salbutamol; inhalant

1.5

169.1

9876

76672

N03AX16

ATC

pregabalin; oral

1.6

164.6

4863

32020

C03CA01

ATC

furosemide; systemic

1.6

164.4

6584

46832

S18

ICPC

Laceration/cut

1.5

163.5

8763

66579

JN4BD

NOMESCO Finland

Extensive body CT

1.9

162.6

2628

14302

J01MA02

ATC

ciprofloxacin; systemic

1.5

161.5

8097

60571

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.2

157.2

886

2795

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

3.9

156.5

696

1819

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

153.9

1909

9343

D01

ICPC

Abdominal pain/cramps general

2.1

153.5

1984

9877

C05AA08

ATC

fluocortolone; rectal, topical

1.8

153.3

3035

17691

UJF92

NOMESCO Finland

Capsular endoscopy

4.5

149.8

567

1276

C07AB07

ATC

bisoprolol; oral

1.5

148.6

10334

82290

A07EC02

ATC

mesalazine; oral, rectal

2.6

148.2

1173

4596

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

15.2

146.3

249

163

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

146.1

8869

68607

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

8.5

145.9

332

390

A02BC01

ATC

omeprazole; systemic

1.5

145.1

5753

40543

K62.1

ICD-10 Finland

Rectal polyp

6.4

144.8

398

619

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.6

143.8

1139

4463

WX110

NOMESCO Finland

Local anesthesy

1.4

140.4

12720

106178

M79.6

ICD-10 Finland

Pain in limb

1.5

139.9

6829

50329

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

139.5

1724

8407

M54.5

ICD-10 Finland

Low back pain

1.5

139.4

5957

42621

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.3

138.7

763

2362

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

138.7

12760

106695

J01CA04

ATC

amoxicillin; systemic

1.5

137.8

15250

132244

AA1AD

NOMESCO Finland

CT of head and brain

1.6

136.5

5117

35487

N06AX11

ATC

mirtazapine; oral

1.5

134.4

5957

42895

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.4

133.1

1228

5218

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

133.1

6904

51398

JFB30

NOMESCO Finland

Right hemicolectomy

4.6

132.7

484

1049

A06AD11

ATC

lactulose; oral

1.7

132.2

3142

19296

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

130.2

3472

22022

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

129.5

6222

45510

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

129.1

4420

29916

J01AA02

ATC

doxycycline; systemic

1.5

127.0

15535

135977

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

125.5

5046

35437

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

125.2

2292

12949

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

123.7

3324

21094

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

4.6

123.4

453

988

G47.3

ICD-10 Finland

Sleep apnoea

1.6

119.6

4080

27511

UKC02

NOMESCO Finland

Cystoscopy

1.6

119.3

3619

23695

K29.7

ICD-10 Finland

Gastritis, unspecified

2.7

117.8

849

3143

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

117.4

3883

25970

SPAT1263

SPAT

Sampling

1.4

117.0

8117

63504

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.6

116.2

886

3390

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

115.6

6741

50998

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

115.4

2842

17566

R53

ICD-10 Finland

Malaise and fatigue

1.6

114.9

3857

25870

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

114.6

5046

36022

JFA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in colon

85.2

114.3

129

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

3.2

114.0

653

2080

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

113.7

7318

56367

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

112.6

1347

6455

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

8.8

112.2

249

281

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

5.0

112.0

381

767

A02BA02

ATC

ranitidine; systemic

1.5

111.6

4126

28291

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

111.1

1910

10533

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

110.4

9008

72304

ZXA00

NOMESCO Finland

Right side

1.5

108.8

5573

40974

K59.0

ICD-10 Finland

Constipation

2.2

108.5

1211

5627

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

107.3

3423

22627

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

9.7

104.7

220

226

K30

ICD-10 Finland

Functional dyspepsia

1.8

104.4

1947

11024

J01MA12

ATC

levofloxacin; systemic

1.5

104.3

3792

25843

R03BB04

ATC

tiotropium bromide; inhalant

1.7

104.3

2207

13012

N05CF01

ATC

zopiclone; oral

1.4

103.1

6416

48862

K51.5

ICD-10 Finland

Left sided colitis

3.3

102.0

553

1692

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

101.9

3662

24873

C10AA05

ATC

atorvastatin; oral

1.4

101.8

8205

65396

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

101.6

3329

22111

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

101.3

5006

36431

R01AD09

ATC

mometasone; nasal

1.4

101.2

7590

59730

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

100.2

2907

18725

A10BA02

ATC

metformin; oral

1.4

98.9

5759

43239

B01AA03

ATC

warfarin; systemic

1.5

98.8

4420

31487

G04CA02

ATC

tamsulosin; oral

1.5

98.6

4982

36388

JN4AD

NOMESCO Finland

Body CT examination

1.9

98.1

1683

9253

ZX120

NOMESCO Finland

Intravenous

1.8

97.2

1908

10974

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.6

97.1

772

3021

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

95.9

1853

10600

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

95.3

1795

10181

J01DA01

ATC

[U] cefalexin; systemic

1.3

94.8

11799

100468

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

94.4

3141

20903

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.5

94.0

776

3099

J01FA06

ATC

roxithromycin; oral

1.4

94.0

7464

59084

H02AB07

ATC

prednisone; oral

1.6

93.6

2784

18018

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

92.9

4991

36813

C08CA01

ATC

amlodipine; oral

1.4

92.8

7539

59870

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.8

92.5

618

2182

R51.80

ICD-10 Finland

Headache

1.7

92.4

2311

14273

M25.5

ICD-10 Finland

Pain in joint

1.4

92.2

4863

35726

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

3.1

91.6

535

1727

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

91.6

12219

104892

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

91.6

5473

41169

K55.2

ICD-10 Finland

Angiodysplasia of colon

6.7

91.5

243

362

UJG02

NOMESCO Finland

Proctoscopy

3.1

91.4

533

1719

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

91.0

2564

16349

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

6.4

90.8

250

391

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

90.2

6172

47538

I84.5

ICD-10 Finland

External hemorrhoids without complication

2.7

90.1

674

2548

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.6

89.4

675

2562

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

88.4

4734

34832

K59.1

ICD-10 Finland

Functional diarrhoea

2.1

88.2

1023

4823

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.9

87.8

1321

6918

Z12.1

ICD-10 Finland

Special screening examination for neoplasm of intestinal tract

7.6

87.4

212

277

ZXA05

NOMESCO Finland

Left side

1.4

87.0

5106

38206

R42

ICD-10 Finland

Dizziness and giddiness

1.5

86.7

4255

30760

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

86.5

9034

74399

WX892

NOMESCO Finland

Monitored bed care

1.8

86.2

1552

8659

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

86.1

2846

18871

M03BX02

ATC

tizanidine; oral

1.3

85.5

10926

92694

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

4.2

85.4

341

809

N03AX12

ATC

gabapentin; oral

1.5

84.8

2877

19190

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

84.6

4645

34291

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

4.2

84.4

336

795

A07EA06

ATC

budesonide; oral, local oral

2.6

83.7

651

2516

XKD00

NOMESCO Finland

Uroflowmetry

1.5

83.6

3464

24157

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

9.2

83.5

180

194

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

83.3

9531

79407

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

83.2

1866

11151

A06AC51

ATC

ispaghula, combinations; systemic

2.1

83.2

1010

4854

R03BA02

ATC

budesonide; inhalant

1.5

82.6

3041

20658

D06

ICPC

Abdominal pain localized other

1.9

82.4

1394

7613

T90

ICPC

Diabetes non-insulin dependent

1.4

81.9

4695

34910

XF402

NOMESCO Finland

ECG with work load test

1.6

81.4

2334

14920

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

81.2

2008

12335

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

80.6

7884

64039

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

79.9

790

3459

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

79.5

3578

25356

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

79.0

2239

14263

E0000UV

ATC

1.3

78.5

6906

55122

D11

ICPC

Diarrhoea

1.7

78.2

1637

9574

K02.1

ICD-10 Finland

Caries of dentine

1.3

78.0

9330

77946

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

77.6

3144

21779

UJD02

NOMESCO Finland

Gastroscopy

2.0

77.6

1019

5059

G44.2

ICD-10 Finland

Tension-type headache

1.6

77.2

2107

13284

D16

ICPC

Rectal bleeding

3.0

77.0

472

1575

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

76.9

1269

6865

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

76.9

4584

34258

K64.0

ICD-10 Finland

First degree haemorrhoids

4.0

76.8

327

823

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

76.8

3152

21891

J02AC01

ATC

fluconazole; systemic

1.3

76.3

6370

50365

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

76.2

8054

66001

A98

ICPC

Health maint/preventive medicine

1.5

75.9

19077

178344

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

75.7

954

4655

N06AB04

ATC

citalopram; systemic

1.4

75.6

3758

27130

L17

ICPC

Foot/toe symptom/complaint

1.4

75.4

4649

34926

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.7

75.3

535

1959

L04AX01

ATC

azathioprine; systemic

2.2

75.0

790

3564

R02

ICPC

Shortness of breath/dyspnoea

1.6

74.4

2269

14708

SPAT1153

SPAT

Removal of sutures

1.3

74.1

6318

50066

M04AA01

ATC

allopurinol; systemic

1.5

73.3

2701

18304

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

73.1

3116

21791

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

73.1

2746

18688

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

72.9

10627

90921

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.4

72.8

641

2648

L03

ICPC

Low back symptom/complaint

1.4

72.8

4124

30489

C10AA01

ATC

simvastatin; oral

1.3

72.6

9419

79282

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

71.9

2485

16590

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

4.3

71.7

276

633

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

29.0

70.9

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

70.6

2740

18767

A10BH01

ATC

sitagliptin; oral

1.6

70.6

1950

12314

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

4.5

70.5

260

572

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

70.5

1277

7125

L01BC06

ATC

capecitabine; oral

2.2

70.3

756

3444

M48.0

ICD-10 Finland

Spinal stenosis

1.5

70.1

2494

16754

J01FF01

ATC

clindamycin; systemic

1.4

69.9

4861

37197

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

4.5

69.7

259

574

Z01.7

ICD-10 Finland

Laboratory examination

1.6

69.5

1948

12350

I84

ICD-10 Finland

Hemorrhoids

2.5

69.2

593

2416

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

69.1

2139

13898

K57

ICD-10 Finland

Diverticular disease of intestine

2.8

69.0

469

1673

A04

ICPC

Weakness/tiredness general

1.6

68.5

2239

14741

JFB21

NOMESCO Finland

Laparoscopic ileocaecal resection

23.0

68.5

100

R05

ICD-10 Finland

Cough

1.4

68.5

3455

24953

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

68.5

2543

17241

N06AX21

ATC

duloxetine; oral

1.6

68.3

1731

10678

2113C

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Colon[ADENOMA TUBULARE COLI]

+∞

68.3

H02AB04

ATC

methylprednisolone; systemic

1.5

68.0

2648

18137

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

3.1

67.9

385

1219

N05BA04

ATC

oxazepam; oral

1.4

67.3

4296

32373

R60.0

ICD-10 Finland

Localized oedema

1.6

67.1

2126

13889

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

67.0

5536

43499

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

66.9

1945

12434

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

66.8

3764

27738

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

66.7

2015

13008

R03AC03

ATC

terbutaline; inhalant

1.5

66.5

2352

15763

2113X

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Colon[NEOPLASMA BENIGNUM ALIUD COLI]

+∞

66.3

R07.3

ICD-10 Finland

Other chest pain

1.6

66.2

1747

10891

J45

ICD-10 Finland

Asthma

1.7

65.7

1627

9970

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

65.6

4224

31850

WX402

NOMESCO Finland

General anaesthesia

1.5

65.5

2751

19139

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

4.7

65.5

234

499

C10AC01

ATC

colestyramine; oral

2.5

65.2

533

2119

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

65.0

6081

48630

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

64.8

1344

7822

UJF34

NOMESCO Finland

Left colonoscopy

5.0

64.5

215

426

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.6

64.4

504

1956

SPAT1301

SPAT

No procedures

1.3

64.3

5957

47549

207

Kela drug reimbursment

Chronic arrhythmias

1.4

64.0

3053

21781

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

64.0

1117

6150

R35

ICD-10 Finland

Polyuria

1.8

63.9

1259

7211

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.8

63.7

1141

6339

C01DA14

ATC

isosorbide mononitrate; oral

1.4

63.2

3250

23520

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

63.1

2687

18732

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

62.6

2073

13670

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

62.2

7092

58226

C03DA01

ATC

spironolactone; oral

1.5

62.1

2103

13937

R06AE07

ATC

cetirizine; oral

1.3

62.1

7136

58651

N06AX16

ATC

venlafaxine; oral

1.6

62.0

2008

13169

A02BC04

ATC

rabeprazole; oral

1.7

61.8

1426

8563

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.6

61.7

472

1806

J01FA10

ATC

azithromycin; systemic

1.3

61.5

9433

80475

A07EA02

ATC

hydrocortisone; rectal

2.7

61.4

445

1652

SPAT1104

SPAT

Monitoring of emergency patient

1.7

61.2

1283

7486

3AC01

NOMESCO Finland

4.0

61.2

257

641

XF404

NOMESCO Finland

Ambulatory ECG

1.6

60.9

1816

11671

SPAT1254

SPAT

Administration of medicine

1.5

60.6

2669

18721

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

60.6

4431

34047

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

59.9

3142

22797

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.0

59.8

862

4432

D18

ICPC

Change in faeces/bowel movements

2.7

59.6

441

1657

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

59.5

6265

50793

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

59.4

3061

22127

Z71.8

ICD-10 Finland

Other specified counselling

1.4

59.3

3750

28123

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

2.8

59.1

391

1371

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

4.4

59.1

223

503

WX290

NOMESCO Finland

Other blockade of nerve

1.3

58.9

6392

52025

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

3.0

58.7

354

1171

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

58.6

4592

35643

R31

ICD-10 Finland

Unspecified haematuria

1.5

58.6

1999

13266

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

58.5

872

4538

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

58.4

2892

20743

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

58.3

1973

13066

A01

ICPC

Pain general/multiple sites

1.7

58.3

1347

8087

R03DC03

ATC

montelukast; oral

1.5

57.9

2483

17311

R13

ICD-10 Finland

Dysphagia

1.7

57.6

1215

7099

D07AC01

ATC

betamethasone; topical

1.3

57.6

6092

49373

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

57.6

1261

7454

R50.9

ICD-10 Finland

Fever, unspecified

1.5

57.5

2356

16266

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.5

57.5

481

1936

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

57.3

1624

10300

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

56.9

1301

7784

WZA90

NOMESCO Finland

Other doctors statement

1.4

56.8

3705

27900

R52.9

ICD-10 Finland

Pain, unspecified

1.6

56.5

1434

8833

J20

ICD-10 Finland

Acute bronchitis

1.6

56.4

1611

10235

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

56.3

1434

8840

R19.4

ICD-10 Finland

Change in bowel habit

2.5

56.1

464

1854

A07AA02

ATC

nystatin; oral

1.7

56.0

1200

7043

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

55.9

7021

58155

SPAT1262

SPAT

Handing over of treatment supplies

1.4

55.9

3500

26170

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.7

55.4

1333

8087

N05CF02

ATC

zolpidem; oral

1.4

55.4

2877

20803

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

55.4

1398

8596

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

2.9

55.3

349

1188

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.3

55.0

526

2265

JFB46

NOMESCO Finland

Resection of sigmoid colon

3.3

55.0

295

899

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

54.8

1757

11483

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

54.7

9316

80055

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

5.5

54.7

167

300

M79.1

ICD-10 Finland

Myalgia

1.5

54.5

1986

13362

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

54.5

3163

23332

A11

ICPC

Chest pain NOS

1.6

54.1

1391

8593

KMAK

NOMESCO Finland

1.3

54.1

8322

70612

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

54.0

6795

56223

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

54.0

1797

11842

M01AH05

ATC

etoricoxib; oral

1.3

54.0

10288

89534

A10AE04

ATC

insulin glargine; parenteral

1.6

53.6

1700

11080

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

6.7

53.6

140

206

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

1.8

53.5

939

5175

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

53.4

1951

13131

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.1

53.4

643

3077

C09CA01

ATC

losartan; oral

1.3

53.3

4648

36568

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

53.1

1930

12972

R01AD08

ATC

fluticasone; nasal

1.3

52.9

4505

35312

D12

ICPC

Constipation

2.1

52.7

638

3058

M02AA07

ATC

piroxicam; topical

1.3

52.5

6879

57159

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

52.5

7373

61794

B82

ICPC

Anaemia other/unspecified

2.3

52.4

493

2109

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

52.4

4119

31902

R11

ICD-10 Finland

Nausea and vomiting

1.6

52.3

1305

7996

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

52.3

5495

44356

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

52.3

1374

8538

B01AF02

ATC

apixaban; oral

1.5

52.2

1945

13143

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.2

52.0

285

883

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

51.6

3548

26895

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

51.6

1632

10622

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

51.4

11947

106096

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

51.0

2575

18499

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

51.0

1082

6330

M10.9

ICD-10 Finland

Gout, unspecified

1.6

51.0

1280

7858

B01AB10

ATC

tinzaparin; parenteral

1.6

50.9

1276

7827

21136

ICD-8 Finland

Benign neoplasm of other parts of digestive system, Coli sigmoidei

+∞

50.7

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

50.6

1844

12398

J01FA09

ATC

clarithromycin; systemic

1.3

49.9

5112

41069

WX722

NOMESCO Finland

PEEP

1.8

49.9

898

4992

SPAT1097

SPAT

Recording of ECG

1.4

49.8

2880

21192

N30.0

ICD-10 Finland

Acute cystitis

1.4

49.7

2275

16033

R63.4

ICD-10 Finland

Abnormal weight loss

2.0

49.6

655

3256

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.5

49.5

2172

15176

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

49.5

3070

22863

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

4.5

49.5

181

397

G04CA01

ATC

alfuzosin; oral

1.4

49.5

2276

16055

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

49.4

5457

44273

M01AB05

ATC

diclofenac; systemic, rectal

1.2

49.3

12084

107699

A03FA02

ATC

cisapride; oral, rectal

1.6

49.3

1452

9288

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

49.1

4240

33252

D64.8

ICD-10 Finland

Other specified anaemias

2.7

49.0

344

1253

130

Kela drug reimbursment

Malignant tumour

1.5

48.8

1602

10512

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

48.7

2885

21316

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

48.7

1783

11995

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

2.4

48.6

421

1727

M01AE02

ATC

naproxen; oral, rectal

1.2

48.5

9689

84337

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

48.4

1355

8553

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

4.5

48.4

176

384

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

47.9

4138

32429

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

47.9

1547

10110

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

47.9

1294

8092

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.4

47.8

427

1779

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.7

47.8

1021

5981

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

47.7

2969

22107

Z01.2

ICD-10 Finland

Dental examination

1.3

47.7

6407

53227

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

47.7

1177

7189

JAH01

NOMESCO Finland

Laparoscopy

1.9

47.2

677

3473

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

47.2

4715

37700

N06AB10

ATC

escitalopram; oral

1.4

47.2

2730

20076

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

47.0

1036

6126

M54

ICD-10 Finland

Dorsalgia

1.5

46.8

1675

11209

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

46.6

5103

41291

JHB00

NOMESCO Finland

Hemorrhoidectomy

2.1

46.6

583

2833

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

46.6

16746

155449

JFB43

NOMESCO Finland

Left hemicolectomy

4.3

46.5

177

404

J01MA14

ATC

moxifloxacin; systemic

1.5

46.5

1552

10217

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

4.6

46.3

166

357

J01EA01

ATC

trimethoprim; systemic

1.3

46.1

4242

33517

K78

ICPC

Atrial fibrillation/flutter

1.5

46.1

1557

10283

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

46.0

2797

20735

D02

ICPC

Abdominal pain epigastric

1.8

45.9

902

5150

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

4.2

45.9

182

432

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

45.9

2785

20638

E66.00

ICD-10 Finland

Metabolic syndrome

1.8

45.9

907

5190

ZXA10

NOMESCO Finland

Bilateral

1.3

45.9

3400

26025

C07AA05

ATC

propranolol; systemic

1.4

45.8

2898

21623

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.6

45.8

1259

7909

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

45.7

1158

7123

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

45.5

1122

6847

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.9

45.4

713

3782

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

45.4

1132

6930

A10BH05

ATC

linagliptin; oral

1.7

45.4

941

5467

L01

ICPC

Neck symptom/complaint

1.4

45.3

2121

15000

A46

ICD-10 Finland

Erysipelas

1.4

45.2

2572

18847

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

45.1

1092

6629

A28

ICPC

Limited function/disability NOS

1.4

45.1

2882

21536

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

5.5

45.0

138

250

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.9

45.0

725

3878

TK800

NOMESCO Finland

Hemodialysis

2.3

45.0

422

1803

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

44.9

2958

22211

R96

ICPC

Asthma

1.5

44.8

1458

9539

WX320

NOMESCO Finland

Spinalanesthesy

1.3

44.8

4097

32326

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

1.6

44.7

1343

8623

K51.8

ICD-10 Finland

Other ulcerative colitis

3.2

44.7

249

782

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

44.7

1868

12916

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

44.5

1315

8410

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

44.3

2687

19898

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.8

44.3

860

4895

B80

ICPC

Iron deficiency anaemia

2.5

44.2

352

1381

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.4

44.1

2782

20738

JF2BD

NOMESCO Finland

Extensive colon CT

3.2

44.1

237

725

R03BA05

ATC

fluticasone; inhalant

1.4

44.1

2862

21438

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

43.9

4443

35526

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

43.9

3190

24324

SPAT1312

SPAT

General health counselling

1.3

43.7

5393

44235

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.4

43.5

2989

22587

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

43.2

3918

30855

E66.8

ICD-10 Finland

Other obesity

1.9

43.1

707

3805

R15

ICD-10 Finland

Faecal incontinence

2.1

42.7

495

2332

B01AC04

ATC

clopidogrel; oral

1.3

42.7

3119

23790

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

42.7

2247

16227

R06AX27

ATC

desloratadine; oral

1.3

42.6

3704

28987

N17

ICPC

Vertigo/dizziness

1.4

42.6

1911

13390

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

42.6

2335

16985

EBA00

NOMESCO Finland

Extraction of tooth

1.3

42.2

5266

43208

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

42.2

1867

13049

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

3.7

42.1

192

517

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

42.0

2369

17317

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

3.1

42.0

245

795

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

42.0

956

5704

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

7.9

41.9

123

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

41.9

1323

8595

C09CA06

ATC

candesartan; oral

1.3

41.7

3707

29087

K29.8

ICD-10 Finland

Duodenitis

3.4

41.7

209

607

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

41.7

993

6000

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

41.7

1193

7566

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

41.3

5257

43217

R03BA01

ATC

beclometasone; inhalant

1.4

41.3

2344

17147

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

41.3

1014

6181

N06AA09

ATC

amitriptyline; systemic

1.5

41.3

1764

12241

A11CC03

ATC

alfacalcidol; systemic

2.2

41.1

436

1974

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

41.0

2054

14693

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.2

40.9

435

1973

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

40.8

2157

15578

R03AC13

ATC

formoterol; inhalant

1.7

40.8

854

4974

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

40.8

1721

11912

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

40.6

3947

31340

N01

ICPC

Headache

1.6

40.5

1174

7469

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

40.5

4100

32733

E000001

ATC

1.3

40.2

3227

24937

205

Kela drug reimbursment

Chronic hypertension

1.2

40.1

5703

47469

D12

ICD-10 Finland

Benign neoplasm of colon, rectum, anus and anal canal

5.3

40.1

126

236

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

40.1

1130

7138

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

5.0

40.0

131

257

GD1AD

NOMESCO Finland

Thorax CT examination

1.8

40.0

781

4453

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

7.0

39.9

101

143

ICD-10 Finland

2.1

39.9

452

2107

Z71.9

ICD-10 Finland

Counselling, unspecified

1.7

39.9

875

5167

K55.8

ICD-10 Finland

Other vascular disorders of intestine

4.9

39.8

133

267

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

39.7

2032

14588

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

39.7

1853

13077

SPAT1216

SPAT

Assessment of functional ability

1.3

39.7

2876

21889

S29

ICPC

Skin symptom/complaint other

1.3

39.6

2879

21919

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

39.5

2961

22652

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

39.3

3744

29629

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.7

39.3

791

4553

R05FB02

ATC

cough suppressants and expectorants

1.2

39.2

6859

58379

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

39.2

3799

30131

K50.8

ICD-10 Finland

Other Crohn disease

2.9

39.2

247

845

J01MA06

ATC

norfloxacin; oral

1.4

39.0

2284

16786

A10BB12

ATC

glimepiride; oral

1.5

39.0

1398

9344

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

39.0

3923

31275

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

38.7

1059

6640

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

2.2

38.6

390

1728

A07EC01

ATC

sulfasalazine; oral, rectal

1.5

38.6

1299

8560

R74

ICPC

Upper respiratory infection acute

1.3

38.5

3516

27660

R05

ICPC

Cough

1.3

38.5

3552

27984

-60

ICPC

Result test/procedure

1.6

38.3

1025

6386

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

38.3

1587

10935

K62.0

ICD-10 Finland

Anal polyp

3.3

38.3

203

616

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.7

38.3

771

4437

I50.0

ICD-10 Finland

Congestive heart failure

1.5

38.2

1343

8937

JN4CD

NOMESCO Finland

Very extensive body CT

1.8

38.2

742

4225

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

38.1

1886

13449

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.3

38.0

364

1573

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

37.9

1396

9386

C10AA07

ATC

rosuvastatin; oral

1.3

37.9

4504

36654

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.2

37.7

5634

47092

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

37.6

3217

25063

N05AH04

ATC

quetiapine; oral

1.4

37.6

2244

16540

8263/2-C18.0

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of cecum

192.1

37.5

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.6

37.5

1105

7058

G04BD12

ATC

mirabegron; oral

1.4

37.4

1884

13479

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

37.3

1568

10837

K22.1

ICD-10 Finland

Ulcer of oesophagus

2.3

37.2

361

1569

M01AC06

ATC

meloxicam; systemic, rectal

1.2

37.1

6404

54353

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

37.0

4346

35294

SFA00

NOMESCO Finland

Small filling

1.4

37.0

1945

14020

XJH00

NOMESCO Finland

Transanal ultrasonography

1.5

37.0

1231

8088

L05

ICPC

Flank/axilla symptom/complaint

1.7

36.9

881

5327

K29.4

ICD-10 Finland

Chronic atrophic gastritis

2.1

36.6

428

2022

M01AX17

ATC

nimesulide; oral

1.3

36.6

4493

36682

SPAT1255

SPAT

Intravenous administration of medicine

1.5

36.5

1140

7379

JFB51

NOMESCO Finland

Other laparoscopic resection of colon

20.1

36.5

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.4

36.5

1594

11095

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

36.5

5026

41588

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.6

36.4

976

6083

A01AB09

ATC

miconazole; local oral

1.5

36.3

1492

10260

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

36.2

7017

60233

K60.1

ICD-10 Finland

Chronic anal fissure

2.2

36.2

365

1618

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

3.3

36.1

187

558

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

36.1

773

4532

SPAT1325

SPAT

Vaccination

1.2

36.1

6500

55375

M01AH01

ATC

celecoxib; oral (coxibs)

1.3

36.1

3150

24601

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

36.0

919

5656

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

35.9

1301

8714

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.7

35.9

715

4099

N18.8

ICD-10 Finland

Other chronic renal failure

1.9

35.9

525

2714

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.7

35.8

249

906

N19

ICD-10 Finland

Unspecified kidney failure

1.8

35.7

619

3397

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.7

35.7

857

5187

N06AB06

ATC

sertraline; oral

1.5

35.6

1452

9966

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.9

35.6

571

3052

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

35.4

614

3371

L15

ICPC

Knee symptom/complaint

1.3

35.4

3485

27658

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.6

35.3

950

5929

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

35.2

597

3250

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.3

35.2

340

1477

Z50.1

ICD-10 Finland

Other physical therapy

1.6

35.1

943

5882

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.4

35.1

1664

11766

WX882

NOMESCO Finland

High dependency care

2.0

35.0

481

2428

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.2

35.0

352

1558

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.7

35.0

745

4358

R33

ICD-10 Finland

Retention of urine

1.5

35.0

1449

9978

X58

ICD-10 Finland

Exposure to other specified factors

1.4

34.8

1977

14442

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

34.7

1613

11357

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.7

34.7

802

4806

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.5

34.7

289

1166

R20.2

ICD-10 Finland

Paraesthesia of skin

1.6

34.6

922

5740

N05BA01

ATC

diazepam; systemic, rectal

1.4

34.6

2215

16503

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

34.6

7700

66923

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.5

34.5

1115

7275

C10AX09

ATC

ezetimibe; oral

1.4

34.4

1978

14476

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

34.4

1184

7839

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.7

34.3

806

4850

A08

ICPC

Swelling

1.7

34.2

734

4305

C07AB02

ATC

metoprolol; systemic

1.3

34.2

3969

32143

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

34.2

980

6217

L16

ICPC

Ankle symptom/complaint

1.4

34.0

1505

10498

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.7

34.0

771

4594

C08CA13

ATC

lercanidipine; oral

1.3

34.0

2430

18419

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.7

33.9

693

4006

K57.1

ICD-10 Finland

Diverticular disease of small intestine without perforation or abscess

2.5

33.9

268

1051

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

33.9

2126

15787

M54.2

ICD-10 Finland

Cervicalgia

1.6

33.7

1029

6626

S97

ICPC

Chronic ulcer skin

1.6

33.6

973

6185

JEA01

NOMESCO Finland

Laparoscopic appendectomy

2.0

33.6

440

2182

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

33.6

685

3958

L13

ICPC

Hip symptom/complaint

1.3

33.6

2750

21263

L08

ICPC

Shoulder symptom/complaint

1.3

33.6

3189

25169

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.8

33.5

553

2987

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.2

33.4

6391

54668

A10AE05

ATC

insulin detemir; parenteral

1.6

33.4

880

5465

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

33.3

1233

8293

A02BDXX

ATC

1.7

33.2

674

3890

JHA20

NOMESCO Finland

Excision of lesion of anal canal or perianal tissue

3.0

33.2

203

680

JG1CG

NOMESCO Finland

Extensive MRI of rectum

4.0

33.1

137

341

A05

ICPC

Feeling ill

1.7

33.1

678

3921

N02AA05

ATC

oxycodone; systemic

1.3

33.1

2629

20235

C02AC05

ATC

moxonidine; oral

1.6

33.0

831

5097

SPAT1285

SPAT

Provision of consultation response

1.6

33.0

911

5724

J37.0

ICD-10 Finland

Chronic laryngitis

1.9

33.0

520

2765

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.6

33.0

871

5412

R19.5

ICD-10 Finland

Other faecal abnormalities

2.5

32.9

260

1017

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.5

32.7

1039

6749

SPAT1260

SPAT

Consultation of another employee

1.3

32.7

3035

23866

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.8

32.7

556

3032

N07BA03

ATC

varenicline; oral

1.7

32.6

654

3760

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

32.5

2068

15384

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

7.2

32.5

110

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

5.4

32.3

181

K92.0

ICD-10 Finland

Haematemesis

2.0

32.3

414

2035

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.3

32.3

3484

27932

U02

ICPC

Urinary frequency/urgency

1.4

32.3

2078

15483

L28

ICPC

Limited function/disability (L)

1.3

32.3

2808

21883

A09AA02

ATC

multienzymes (lipase, protease etc.)

2.1

32.1

365

1709

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

4.6

32.1

113

241

J46

ICD-10 Finland

Status asthmaticus

2.0

32.0

438

2211

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

4.9

31.9

106

213

C09AA05

ATC

ramipril; oral

1.2

31.8

4763

39663

JGA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in rectum

9.7

31.7

R03BA08

ATC

ciclesonide; inhalant

1.5

31.7

1217

8244

R4190

NOMESCO Finland

Nutritional therapy

1.9

31.6

456

2349

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

31.5

1296

8905

WW500

NOMESCO Finland

Blood transfusion

1.7

31.5

667

3899

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.4

31.4

1397

9749

K22.7

ICD-10 Finland

Barrett oesophagus

2.5

31.4

252

997

XG410

NOMESCO Finland

Flow-volume spirometry

1.7

31.4

696

4121

S21

ICPC

Skin texture symptom/complaint

1.3

31.2

2051

15330

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.7

31.2

630

3630

N05CD07

ATC

temazepam; oral

1.3

31.2

2253

17092

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.8

31.1

601

3417

A02BA04

ATC

nizatidine; systemic

1.4

31.1

1389

9704

21139

ICD-8 Finland

Benign neoplasm of other parts of digestive system, Coli NUD

+∞

31.1

N06AB03

ATC

fluoxetine; oral

1.4

30.9

1890

13962

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.6

30.9

919

5877

D75

ICPC

Malignant neoplasm colon/rectum

3.2

30.8

163

497

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

30.6

983

6404

K96

ICPC

Haemorrhoids

2.1

30.6

376

1818

UJF02

NOMESCO Finland

Peroral enteroscopy

3.6

30.6

142

391

L72.1

ICD-10 Finland

Trichilemmal cyst

1.5

30.5

962

6239

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.6

30.5

229

874

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.8

30.4

504

2727

J01DA06

ATC

[U] cefuroxime; systemic

1.3

30.4

2293

17498

R10.0

ICD-10 Finland

Acute abdomen

1.9

30.3

473

2505

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

30.2

905

5801

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.1

30.1

368

1776

K29.6

ICD-10 Finland

Other gastritis

2.6

30.1

225

856

S82

ICPC

Naevus/mole

1.4

30.1

1862

13782

D50

ICD-10 Finland

Iron deficiency anaemia

2.3

30.1

274

1159

D13.3

ICD-10 Finland

Benign neoplasm: Other and unspecified parts of small intestine

4.2

30.0

116

272

R03DA04

ATC

theophylline; systemic, rectal

1.6

29.9

894

5723

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

29.9

1643

11918

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

2.9

29.9

190

655

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.5

29.9

1035

6859

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.4

29.7

1483

10575

1381

FHL

Colonoscopy and polyp removal

32.0

29.7

I50

ICD-10 Finland

Heart failure

1.8

29.6

559

3156

R4120

NOMESCO Finland

Occupational therapy

1.5

29.6

974

6378

H25.8

ICD-10 Finland

Other senile cataract

1.3

29.6

2030

15269

N05BA12

ATC

alprazolam; oral

1.4

29.5

1576

11376

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.4

29.4

1293

9002

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.0

29.4

389

1937

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

6.5

29.4

116

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.4

29.4

1301

9075

R60.9

ICD-10 Finland

Oedema, unspecified

1.6

29.3

786

4901

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.5

29.3

1189

8151

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.2

29.3

4072

33591

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.5

29.2

953

6228

UJF30

SPAT

4.4

29.2

109

247

A10BK03

ATC

empagliflozin; oral

1.5

29.2

1145

7792

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.0

29.1

403

2045

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.4

29.1

1869

13908

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.4

29.0

249

1021

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

1.5

29.0

966

6345

R04.0

ICD-10 Finland

Epistaxis

1.4

29.0

1256

8717

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.7

29.0

560

3185

2113A

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Colon[ADENOMA VILLOSUM COLI]

+∞

29.0

N18.0

ICD-10 Finland

End-stage renal disease

2.5

29.0

226

882

R01AD12

ATC

fluticasone furoate; nasal

1.2

28.9

4000

32970

Z31.5

ICD-10 Finland

Genetic counselling

1.8

28.9

543

3061

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.5

28.9

226

884

U05

ICPC

Urination problems other

1.6

28.8

788

4937

R04.2

ICD-10 Finland

Haemoptysis

1.7

28.8

592

3430

K58

ICD-10 Finland

Irritable bowel syndrome

2.1

28.8

318

1472

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

7.0

28.7

102

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

28.5

451

2402

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

28.5

665

3997

D78

ICPC

Neoplasm digestive benign/unspecif

7.8

28.5

SPAT1310

SPAT

Counselling related to known health issue

1.2

28.4

5432

46286

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.0

28.4

375

1866

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

2.6

28.4

208

784

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.5

28.3

1132

7732

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

28.3

530

2983

R51

ICD-10 Finland

Headache

1.7

28.3

645

3851

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.0

28.3

361

1776

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.4

28.2

1513

10925

R07.0

ICD-10 Finland

Pain in throat

1.6

28.2

748

4649

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

28.2

1630

11926

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.2

28.2

3547

28918

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.5

28.1

1128

7715

B03XA02

ATC

darbepoetin alfa; parenteral

2.1

28.0

324

1529

-50

ICPC

Medication/prescr/renewal

1.6

28.0

705

4325

XQ800

NOMESCO Finland

Prick test

1.5

28.0

893

5811

P03

ICPC

Feeling depressed

1.5

27.9

903

5890

XG466

NOMESCO Finland

Sleep oxymetry

1.7

27.9

546

3116

D07AA02

ATC

hydrocortisone; topical

1.3

27.9

1871

14017

AN1

Coronary angiography

1.3

27.9

2270

17506

I20.09

ICD-10 Finland

Unstable angina

1.5

27.8

1041

7015

R03AC12

ATC

salmeterol; inhalant

1.6

27.7

746

4656

U07

ICPC

Urine symptom/complaint other

1.5

27.7

947

6255

R06.5

ICD-10 Finland

Mouth breathing

1.4

27.7

1288

9062

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.0

27.6

160

521

WX004

NOMESCO Finland

Patient-controlled sedation

3.7

27.5

121

319

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

27.5

1426

10234

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.5

27.5

223

889

R55

ICD-10 Finland

Syncope and collapse

1.3

27.5

1850

13868

M54.3

ICD-10 Finland

Sciatica

1.5

27.4

905

5931

B01AB04

ATC

dalteparin; parenteral

1.6

27.4

832

5351

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

5.4

27.4

151

R12

ICD-10 Finland

Heartburn

1.5

27.3

1030

6954

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

27.2

6304

54654

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.5

27.1

1104

7566

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.0

27.1

371

1876

G04BD08

ATC

solifenacin; oral

1.4

27.0

1180

8206

JAH00

NOMESCO Finland

Laparotomy

1.8

27.0

457

2494

H26.4

ICD-10 Finland

After-cataract

1.4

26.9

1636

12063

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.7

26.9

603

3582

R21

ICPC

Throat symptom/complaint

1.3

26.9

2246

17377

D07AC13

ATC

mometasone; topical

1.2

26.8

4723

39876

L14

ICPC

Leg/thigh symptom/complaint

1.4

26.8

1184

8250

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.6

26.8

206

799

N30

ICD-10 Finland

Cystitis

1.5

26.8

1016

6864

R03AK08

ATC

formoterol and beclometasone; inhalant

1.7

26.8

555

3224

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

3.3

26.7

135

399

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.3

26.7

249

1068

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

5.1

26.7

168

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.6

26.6

640

3879

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.0

26.5

325

1573

N06AX26

ATC

vortioxetine; oral

1.7

26.5

624

3762

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

26.5

2341

18248

B01AF01

ATC

rivaroxaban; oral

1.3

26.3

2135

16446

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.4

26.3

226

930

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.9

26.2

416

2220

R06AX22

ATC

ebastine; oral

1.3

26.2

2355

18397

A04.8

ICD-10 Finland

Other specified bacterial intestinal infections

2.3

26.2

256

1121

C187, 8211, 2

ICD-O-3

33.5

26.2

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

26.1

697

4340

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.5

26.1

1090

7511

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019309) Folate [Moles/volume] in Red Blood Cells

6756

42389

1.78

315.03

1.8

1123.8

1166.9

nmol/l

3.15

5180

31565

(42870588) Differential panel, method unspecified - Blood

10186

68784

1.77

307.65

6.7

5.8

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

6576

36630

2.04

307.65

1.3

1.2

1.6

1.8

u/ml

0.27

1510

9453

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

7741

49246

1.79

307.65

2.9

2.4

—

(3002030) Lymphocytes/100 leukocytes in Blood

12903

94449

1.72

307.65

7.3

6.1

26.2

26.9

9.81

11983

87282

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

12992

88219

1.95

307.65

2.4

2.0

94.5

94.8

pmol/l

0.20

7182

45301

(40768804) Tissue Pathology biopsy report

12180

79810

1.99

307.65

2.5

2.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

4567

24974

1.97

307.65

2.5

2.4

1.8

1.27

4024

21936

(3022145) Colonoscopy Study observation

9058

18841

6.90

307.65

1.5

1.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

15617

107595

2.17

307.65

7.1

6.3

11.4

11.8

umol/l

2.65

14905

101927

(3018010) Neutrophils/100 leukocytes in Blood

12782

92944

1.73

307.65

7.1

5.9

58.6

58.0

7.84

11893

86293

(3004789) Transferrin [Mass/volume] in Serum or Plasma

5762

30731

2.10

307.65

3.2

2.5

2.3

g/l

11.69

5371

28223

(3007164) IgA [Mass/volume] in Serum or Plasma

5905

32330

2.04

307.65

1.5

2.6

g/l

0.74

3296

18834

(3013115) Eosinophils [#/volume] in Blood

14219

101469

1.89

307.65

7.1

5.9

0.2

e9/l

2.92

12460

87892

(3019069) Monocytes/100 leukocytes in Blood

12734

92602

1.73

307.65

7.5

6.3

8.8

0.52

11896

86099

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

20169

157123

2.50

307.65

9.9

7.6

80.3

79.8

u/l

0.69

19259

147260

(3031040) Bacteria [#/volume] in Urine by Automated count

17163

133806

1.87

307.65

5.9

4.7

406.6

1539.2

e6/l

5.35

145

2137

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

14538

107015

1.82

307.65

8.7

6.7

1.2

mmol/l

10.21

12850

89357

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2623

11160

2.46

307.65

2.7

2.4

—

(3006504) Eosinophils/100 leukocytes in Blood

12680

92108

1.73

307.65

7.2

6.0

2.8

2.9

2.59

11813

85316

(3019198) Lymphocytes [#/volume] in Blood

14056

100339

1.88

307.65

7.0

5.8

1.9

e9/l

1.32

12354

87149

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

22296

194309

2.47

307.65

23.3

15.7

25.8

25.6

mg/l

0.41

19206

156692

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

5307

22627

2.66

307.65

4.4

3.9

18.3

25.5

ug/l

0.58

4454

18568

(3022948) Iron [Moles/volume] in Serum or Plasma

6136

33071

2.09

307.65

3.2

2.5

11.8

12.6

umol/l

14.51

5748

30390

(3013650) Neutrophils [#/volume] in Blood by Automated count

15582

114136

1.94

307.65

10.1

9.1

4.3

4.2

e9/l

2.15

13641

99016

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

9248

51637

2.22

307.65

2.9

2.2

3.3

3.0

mg/l

18.94

8051

43653

(3013707) Erythrocyte sedimentation rate by Westergren method

18671

147209

2.04

307.65

5.2

4.2

14.3

13.5

mm/h

9.76

17289

134962

(3024561) Albumin [Mass/volume] in Serum or Plasma

13838

91584

2.11

307.65

6.2

4.7

35.0

34.9

g/l

1.00

13029

84423

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

12932

93934

1.74

307.65

4.7

4.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

10153

64497

1.93

307.65

3.0

2.5

58.8

59.2

u/l

0.25

9445

59115

(40768797) Stomach Pathology biopsy report

5858

27216

2.46

307.65

1.3

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

8088

51779

1.79

307.65

5.2

3.9

87.6

0.01

7922

50513

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5488

28838

2.11

307.65

3.3

2.5

20.6

22.3

15.78

4754

24262

(3032080) INR in Blood by Coagulation assay

12401

89509

1.73

307.65

11.6

9.8

1.3

inr

0.45

2713

25248

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

13540

97221

1.82

307.65

7.5

6.0

1.2

mmol/l

5.75

12387

87387

(3048689) Calprotectin [Mass/mass] in Stool

4723

19462

2.71

307.65

2.4

2.1

147.9

149.8

ug/g

0.12

3765

15002

(3001604) Monocytes [#/volume] in Blood

13807

97933

1.88

307.65

6.9

5.7

0.6

e9/l

0.22

11947

83554

(3022096) Basophils/100 leukocytes in Blood

12353

89563

1.71

307.65

7.2

6.0

0.7

1.03

11507

83012

(3013826) Glucose [Moles/volume] in Serum or Plasma

15871

122034

1.79

307.65

6.1

4.8

6.9

6.8

mmol/l

3.85

15061

114817

(3001122) Ferritin [Mass/volume] in Serum or Plasma

11990

77608

2.01

307.65

3.8

2.8

134.0

155.1

ug/l

10.83

11088

70578

(3044640) Blood type and Crossmatch panel - Blood

9838

64507

1.83

307.65

3.0

2.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

17502

138343

1.85

307.65

5.6

4.5

—

(3006315) Basophils [#/volume] in Blood

13884

98485

1.89

307.65

6.9

5.7

0.0

e9/l

0.43

12005

84091

(3021960) Folate [Moles/volume] in Serum or Plasma

7742

50783

1.72

306.87

1.7

1.6

20.6

20.3

nmol/l

0.59

6728

42858

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3130

15326

2.15

304.89

1.7

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

15330

120617

1.66

295.57

4.1

3.1

60.2

53.4

u/l

10.81

14188

110524

(3014576) Chloride [Moles/volume] in Serum or Plasma

4755

27360

1.87

291.52

7.6

6.9

104.4

104.3

mmol/l

0.85

4678

26714

(3023368) Bacteria identified in Blood by Culture

8732

59978

1.66

286.28

5.0

4.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4111

22724

1.93

284.34

3.1

2.7

8.3

9.3

umol/l

2.21

3606

19781

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3491

18268

2.02

282.94

2.8

2.4

48.8

45.6

u/l

0.14

2985

15583

(40758558) Short blood count panel - Blood

7551

50184

1.69

279.31

7.6

7.0

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

9453

66815

1.63

273.14

3.5

3.0

1730.4

1531.8

ng/l

2.69

8257

57741

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2242

10043

2.31

270.04

1.7

1.6

g/l

0.22

1942

8502

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5836

36508

1.74

267.42

3.2

2.8

1.2

e6/l

0.28

3551

20986

(3015736) pH of Urine

10354

75726

1.59

253.80

4.5

3.6

5.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8826

62177

1.61

253.13

3.7

3.2

35.6

35.1

u/l

0.13

8282

58609

(3018095) Leukocytes [#/volume] in Urine

10118

73747

1.59

250.68

4.7

3.8

79.3

115.3

e6/l

5.51

7409

53249

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3575

19626

1.92

249.45

2.6

2.1

0.2

g/l

7.97

3344

18125

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

10989

81871

1.57

246.09

2.6

2.2

78.2

79.1

nmol/l

2.90

9726

72129

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

20518

177880

1.82

243.56

5.6

4.8

2.1

mu/l

0.27

18839

160309

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

17563

146566

1.62

233.93

4.4

4.0

15.0

pmol/l

0.20

15974

131189

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5365

33841

1.71

233.79

3.5

3.0

2.5

e6/l

0.00

3115

18467

(3023520) Reticulocytes [#/volume] in Blood

3431

18980

1.90

232.55

2.6

2.5

69.8

68.9

e9/l

0.82

2637

14473

(3011397) Hemoglobin [Presence] in Urine by Test strip

6932

46848

1.63

230.79

4.6

3.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

9735

71257

1.56

230.78

3.7

3.4

2.4

mmol/l

1.95

8268

61311

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

10937

82260

1.55

228.93

4.7

3.8

42.3

73.0

ng/l

3.86

8188

60774

(40761511) CBC panel - Blood by Automated count

22308

199671

2.12

228.20

22.2

14.9

—

(3030467) Casts [#/volume] in Urine by Automated count

8360

59267

1.58

226.91

3.9

3.2

0.4

0.5

e6/l

0.21

6467

44862

(3019550) Sodium [Moles/volume] in Serum or Plasma

22713

204826

2.28

226.14

27.1

18.4

139.6

139.7

mmol/l

3.43

22361

199586

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1474

5908

2.54

225.97

1.5

1.4

268.2

264.0

ug/g

0.33

906

3498

(3000991) Gas panel - Venous blood

3259

17934

1.90

223.82

8.7

8.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1337

5153

2.63

222.11

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

1337

5167

2.62

220.87

1.3

1.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3514

19923

1.85

219.44

4.8

3.7

5.8

kpa

1.26

3399

19374

(3023103) Potassium [Moles/volume] in Serum or Plasma

22720

205273

2.25

218.94

27.4

18.6

4.0

mmol/l

0.49

22342

199716

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1321

5110

2.62

217.75

1.3

1.2

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4248

25551

1.76

217.55

7.2

7.0

5.1

kpa

0.01

4049

24363

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4233

25444

1.76

217.25

3.9

4.2

238.4

247.2

u/l

1.74

3981

23963

(3002032) Base excess in Venous blood by calculation

3501

19892

1.84

216.91

4.8

3.7

1.7

1.9

mmol/l

2.32

2890

16250

(3027801) Oxygen [Partial pressure] in Arterial blood

4243

25536

1.76

216.76

7.2

7.0

12.0

12.2

kpa

1.48

4032

24343

(3003396) Base excess in Arterial blood by calculation

4239

25512

1.76

216.53

7.3

7.0

0.9

1.1

mmol/l

2.29

3365

20202

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4543

27905

1.73

215.80

7.5

5.5

1.1

1.0

mmol/l

6.30

4238

25777

(36304419) Bacteria [Presence] in Urine

8009

56913

1.56

211.41

3.9

3.2

—

(3012544) pH of Venous blood

3587

20727

1.81

209.75

4.8

3.7

7.4

0.32

106

(3014111) Lactate [Moles/volume] in Serum or Plasma

3350

19028

1.84

206.97

7.1

6.7

1.3

1.4

mmol/l

0.42

3224

18333

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

6277

42354

1.61

205.82

2.0

1.7

1.3

1.4

mg/l

1.17

4911

32990

(3026493) Urate [Moles/volume] in Serum or Plasma

7761

55163

1.55

202.59

3.2

2.7

4630.8

5262.5

umol/l

0.65

6697

46954

(3035350) Ketones [Presence] in Urine by Test strip

12391

97302

1.50

201.89

4.7

3.8

0.0

estimate

1.08

1625

18487

(3002582) Erythrocytes [#/volume] in Urine

8821

64597

1.53

200.29

4.1

3.3

80.8

101.9

e6/l

0.72

6903

49826

(3042936) Bacteria identified in Isolate by Culture

4687

29582

1.68

199.48

2.3

2.0

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2920

16127

1.88

196.46

4.7

3.7

104.0

92.6

ng/l

7.26

2565

13651

(3009261) Glucose [Presence] in Urine by Test strip

12502

98751

1.49

195.14

4.8

3.9

0.0

estimate

0.25

1619

18270

(3020779) Urea [Moles/volume] in Serum or Plasma

3367

19477

1.80

194.97

9.5

6.7

11.1

10.5

mmol/l

4.27

3187

18423

(3024354) Oxygen [Partial pressure] in Venous blood

2928

16250

1.87

193.85

3.9

3.1

4.6

4.5

kpa

0.41

2821

15722

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

8881

65557

1.51

191.93

2.3

2.1

196.1

213.4

u/l

1.16

8344

61089

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1707

7839

2.22

191.25

3.4

961.3

1637.9

u/ml

0.60

1458

6715

(3021601) Nitrite [Presence] in Urine by Test strip

12350

97581

1.49

190.58

6.4

5.1

0.0

estimate

2.09

1697

18744

(3016502) Oxygen saturation in Arterial blood

3802

22949

1.74

189.63

7.6

7.3

95.5

0.04

3688

22076

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

20767

183862

1.72

187.49

7.8

6.2

41.1

40.4

mmol/mol

19.09

19330

167828

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

22714

206837

2.12

186.91

15.0

11.0

25.6

25.8

u/l

0.94

22161

198345

(36660697) Celiac disease serology panel - Serum

2482

13268

1.93

183.79

1.2

—

(3026008) Bacteria identified in Urine by Culture

8742

64789

1.50

182.86

3.8

3.3

—

(3018418) pH of Serum or Plasma

8632

63842

1.50

182.20

5.2

4.1

7.4

0.51

1113

12511

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

5854

39926

1.57

178.97

3.5

3.1

2.5

mmol/l

0.18

5015

34862

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3496

20965

1.74

177.38

8.0

7.8

118.7

120.9

g/l

8.50

3397

20211

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5041

33274

1.61

176.80

2.3

2.0

30.1

29.9

1.58

4902

32263

(3003327) Ova and parasites identified in Stool by Light microscopy

1268

5326

2.40

174.70

1.8

1.7

—

(3026782) Osmolality of Urine

6082

42050

1.55

174.28

3.3

2.8

541.1

546.8

mosm/kgh2o

0.32

5035

35887

(3004716) Salmonella sp identified in Stool by Organism specific culture

1573

7266

2.20

173.21

1.4

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

19397

169773

1.58

171.60

25.4

17.0

38.5

39.2

19.30

12654

111699

(3020564) Creatinine [Moles/volume] in Serum or Plasma

22652

206929

2.03

170.76

27.0

18.6

84.9

80.4

umol/l

40.54

22646

206839

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5149

34654

1.58

164.61

3.7

3.2

0.8

mmol/l

6.26

4795

32084

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6047

42195

1.54

164.48

4.7

3.9

551.3

484.3

ng/l

0.18

5090

34751

(3022217) INR in Platelet poor plasma by Coagulation assay

4646

30531

1.61

164.37

33.3

26.6

1.6

1.4

inr

4.60

382

4365

(3014007) Fractional oxyhemoglobin in Arterial blood

2501

13881

1.85

163.85

8.7

8.8

93.7

93.8

0.67

2495

13827

(3007853) Bacteria identified in Skin by Aerobe culture

3797

23861

1.66

160.37

2.0

1.8

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1905

9744

1.99

159.47

4.9

4.0

24.0

24.2

mmol/l

1.57

1711

8725

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1626

7871

2.10

158.34

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2272

12375

1.88

157.63

1.3

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

3128

18782

1.72

156.37

2.5

2.6

66.0

66.3

g/l

1.76

2816

16971

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2468

13848

1.83

155.66

8.7

0.7

0.17

2457

13751

(3020682) Albumin/Creatinine [Ratio] in Urine

9081

69401

1.45

154.95

4.4

4.0

12.3

8.8

mg/mmol

7.66

6080

43148

(3037522) Nuclear Ab [Titer] in Serum

3858

24597

1.64

153.23

1.4

1.3

476.0

541.2

titre

1.57

819

5329

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2463

13891

1.82

152.59

8.6

1.4

1.68

2449

13789

(3000850) Epithelial cells [#/volume] in Urine

6327

45263

1.50

150.43

3.0

2.7

4.6

5.1

e6/l

2.73

5433

39640

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

12429

101037

1.42

148.37

2.7

2.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

20626

184901

1.60

145.73

20.5

15.0

75.0

76.3

ml/min/173m2

14.43

17595

153162

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5169

35714

1.53

144.03

2.1

1.8

—

(3025941) Bacteria identified in Stool by Culture

1891

10009

1.92

142.61

1.4

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

8762

67370

1.43

140.68

3.5

3.2

7.3

mmol/l

1.18

7365

55683

(3012516) Albumin [Mass/volume] in Urine

8595

65885

1.43

140.23

3.6

3.2

499.7

415.5

mg/l

0.82

5794

41248

(3007461) Platelets [#/volume] in Blood

23002

212965

2.04

140.12

35.1

23.1

245.8

245.5

e9/l

0.30

22621

206483

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

21216

191916

1.64

139.46

5.8

4.9

6.2

6.0

mmol/l

30.44

19495

172595

(3035941) MCH [Entitic mass]

23001

213032

2.03

138.69

35.0

23.0

30.3

30.4

9.33

22777

209352

(3024731) MCV [Entitic volume]

23003

213063

2.04

138.58

35.0

23.0

91.5

0.27

22778

209375

(3026361) Erythrocytes [#/volume] in Blood

23003

213072

2.03

138.42

35.1

23.1

4.4

e12/l

72.53

22547

205768

(3010813) Leukocytes [#/volume] in Blood

23004

213098

2.03

138.18

35.2

23.1

6.9

6.8

e9/l

14.43

22547

205836

(3019150) Specific gravity of Urine by Refractometry

5961

42729

1.48

138.17

5.3

4.3

1.0

kg/l

0.49

934

6553

(3000963) Hemoglobin [Mass/volume] in Blood

23004

213102

2.03

138.11

35.4

23.2

131.6

134.5

g/l

143.30

22780

209433

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2108

11704

1.84

136.70

8.8

24.1

24.4

mmol/l

2.81

1947

10878

(3004588) Protein electrophoresis panel - Serum or Plasma

2618

15679

1.71

130.48

2.3

2.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

21591

196763

1.66

130.46

6.0

5.3

2.6

2.7

mmol/l

52.75

19983

178647

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1338

6465

2.09

130.28

1.7

1.6

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1449

7213

2.03

130.11

1.1

133.8

233.8

titre

1.15

180

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

20446

184089

1.55

128.50

4.7

4.2

1.4

1.3

mmol/l

29.21

18628

165370

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1525

7779

1.98

127.75

3.1

2.8

0.3

0.4

u/ml

3.09

878

4477

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3117

19709

1.63

125.74

2.6

2.4

6.2

7.3

ug/l

2.76

2693

17050

(40761535) Cells panel - Urine sediment

2873

17816

1.66

125.17

4.4

3.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3712

24522

1.57

124.43

1.9

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3696

24513

1.56

121.47

2.0

1.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2737

16892

1.66

121.22

1.7

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

20970

190487

1.56

119.84

5.2

4.7

1.4

1.5

mmol/l

34.76

19307

172603

(3044889) 12 lead EKG panel

16462

142917

1.39

119.55

4.9

4.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1954

11093

1.79

116.93

1.8

1.9

1.4

1.3

g/l

0.29

1784

9977

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

21107

192239

1.56

116.62

5.3

4.7

4.5

4.6

mmol/l

54.47

19635

175316

(3000494) Fungus identified in Specimen by Culture

3518

23279

1.56

116.31

1.6

1.4

—

(4010399)

2455

14886

1.68

116.04

1.5

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2362

14198

1.70

115.31

2.7

2.8

10.6

g/l

0.06

2181

12926

(3004119) Hemoglobin [Mass/volume] in Venous blood

2218

13155

1.72

113.68

4.3

3.3

124.7

128.2

g/l

10.19

2168

12837

(3019060) Gas panel - Arterial blood

2455

14986

1.67

112.94

4.8

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1605

8686

1.87

112.12

2.2

2.3

3.9

3.8

g/l

0.07

1093

6161

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1606

8707

1.86

111.54

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1607

8717

1.86

111.43

2.3

7.4

7.5

g/l

0.16

1134

6437

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2216

13219

1.71

111.08

1.9

1.7

—

(3013512) EKG study

8119

63528

1.38

109.95

5.0

4.1

—

(3003338) MCHC [Mass/volume]

17746

157115

1.39

106.51

31.3

20.6

330.6

331.9

g/l

61.55

17624

155848

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3912

26965

1.50

106.02

10.3

7.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2840

18248

1.59

105.84

1.7

1.5

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1778

10117

1.78

105.15

3.4

2.7

1.2

0.74

1772

10061

(3021589) Normoblasts [#/volume] in Blood

10656

87387

1.35

105.11

12.0

10.1

0.0

e9/l

2.41

8684

71538

(3034770) Mitochondria Ab [Titer] in Serum

1025

4875

2.11

103.67

1.3

1.2

833.7

925.1

titre

0.14

147

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1495

8137

1.85

102.30

2.3

10.2

10.3

g/l

0.18

1216

6744

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1736

9904

1.77

101.62

3.4

2.7

0.7

0.43

1676

9493

(3007566) Smooth muscle Ab [Titer] in Serum

1022

4899

2.09

101.21

1.3

1.2

104.2

147.2

titre

1.04

420

(3000492) Spirometry study

2606

16603

1.60

100.30

1.6

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1490

8153

1.84

100.18

2.3

3.1

g/l

0.83

1114

6280

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1221

6280

1.95

99.29

1.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1999

12001

1.69

97.24

9.7

9.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1367

7367

1.87

96.39

2.4

2.5

0.9

1.0

g/l

0.63

1156

6226

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1594

9034

1.78

95.25

1.5

12.2

16.8

u/ml

0.71

217

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

647

2642

2.44

94.28

2.8

2.5

195.7

954.5

u/ml

1.31

636

2591

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2644

17153

1.57

93.77

2.3

363.2

377.6

nmol/l

3.18

2426

15707

(46235355) HIV 1 and 2 tests - Meaningful Use set

3108

20899

1.52

93.72

1.8

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1219

6389

1.91

93.61

2.3

0.0

g/l

0.07

1088

5813

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2048

12503

1.66

93.27

1.6

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1263

6723

1.89

92.47

2.3

2.2

37.4

37.3

g/l

0.03

1055

5716

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1032

5144

2.01

91.72

1.7

1.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1143

5948

1.93

89.62

2.4

2.3

0.0

g/l

0.44

1013

5396

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1373

7589

1.82

89.07

2.4

2.3

465.4

582.2

ug/l

0.69

1290

7174

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2780

18447

1.54

88.80

1.8

1.7

1.6

1.5

7.32

2326

15748

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1124

5858

1.92

87.70

2.4

0.0

g/l

0.00

1012

5375

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1099

5689

1.93

87.50

1.5

1.4

14.1

15.1

iu/ml

0.07

137

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1466

8344

1.77

86.09

4.7

3.9

24.6

25.0

mmol/l

3.59

1348

7629

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2916

19686

1.51

85.70

3.3

2.9

240.3

221.6

ng/l

1.18

2657

18077

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1669

9896

1.70

84.61

5.3

4.0

48.3

47.4

0.79

1660

9780

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

4318

31600

1.41

82.90

1.3

29.4

40.3

iu/ml

5.69

1330

9859

(3002256) Pathology report gross observation

3766

26952

1.44

81.82

1.4

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2189

14065

1.58

80.25

7.4

7.1

24.6

mmol/l

0.27

2065

13109

(3022313) Gas panel - Capillary blood

1636

9796

1.68

79.80

4.4

3.7

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2509

16656

1.53

79.41

2.9

2.8

60.7

62.0

ml/min/173m2

0.94

1091

6808

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1250

6951

1.80

79.30

1.6

216.8

255.9

titre

0.21

334

(3020891) Body temperature

1494

8772

1.71

78.35

5.4

4.8

—

(3002385) Erythrocyte distribution width [Ratio]

17503

157303

1.32

76.51

28.7

19.1

14.1

13.8

75.04

17264

153776

(3027273) Bicarbonate [Moles/volume] in Venous blood

1745

10770

1.63

75.48

4.6

3.4

25.0

25.3

mmol/l

2.00

1705

10467

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4046

29710

1.40

75.29

1.3

1.2

14.9

14.1

u/ml

0.15

1360

10814

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2053

13185

1.57

75.19

4.3

3.5

1.4

1.9

mmol/l

6.17

1537

9845

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2137

13857

1.56

75.02

4.3

3.6

5.1

5.2

kpa

0.72

1980

12714

(3037121) Protein [Mass/volume] in Urine

1266

7181

1.77

75.00

3.1

3.0

0.3

g/l

0.22

574

3017

(3009343) pH of Capillary blood

2108

13687

1.56

73.49

4.3

3.6

7.4

3.09

194

1869

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

870

4413

1.96

73.39

1.5

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

859

4360

1.96

72.32

1.4

1.3

—

(4035726)

2738

18915

1.47

70.83

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

379

1386

2.70

69.42

1.3

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

1134

6400

1.77

68.25

4.0

3.3

—

(3018405) Lactate [Moles/volume] in Arterial blood

1327

7831

1.70

68.08

4.3

4.1

1.4

mmol/l

0.20

1303

7689

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1279

7516

1.70

66.62

2.8

3.3

38.7

45.1

mg/l

1.53

1110

6035

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1319

7817

1.69

66.57

2.8

2.7

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

877

4608

1.90

66.56

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

877

4609

1.90

66.51

1.4

1.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1280

7531

1.70

66.37

2.8

3.3

63.7

67.3

mg/l

0.13

1111

6040

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1247

7301

1.71

65.83

2.8

3.3

2.6

4.9

ratio

0.80

591

(3024980) IgG subclass 4 [Mass/volume] in Serum

623

2916

2.12

65.53

1.7

1.5

0.7

0.8

g/l

1.93

483

2170

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3226

23290

1.41

65.32

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

8943

74785

1.27

64.81

5.2

4.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

994

5490

1.81

64.31

2.6

2.3

3.7

3.6

g/l

1.17

954

5226

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

9264

77848

1.27

64.31

5.6

5.2

3.1

3.6

ug/l

0.59

8325

69291

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

973

5357

1.81

63.61

1.6

18.8

7.4

iu/ml

0.37

241

1219

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1197

7002

1.71

63.36

1.1

3.5

7.2

u/ml

0.39

106

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

821

4290

1.90

63.35

1.1

6.1

8.5

u/ml

0.50

410

(3043409) Potassium [Moles/volume] in Arterial blood

1155

6714

1.72

62.54

4.5

4.4

3.9

mmol/l

2.15

1109

6282

(3019225) pH of Specimen

3053

22062

1.41

61.14

5.2

4.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

832

4424

1.87

60.82

3.7

2.4

35.3

33.3

umol/l

1.32

711

3675

(3024928) Oxygen saturation in Venous blood

815

4397

1.84

56.88

3.5

3.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1681

10995

1.53

56.10

1.4

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

859

4737

1.80

55.80

3.1

3.3

171.6

903.9

u/ml

4.12

778

4303

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

966

5514

1.75

55.76

2.3

2.1

90.2

89.4

0.48

916

5136

(3005988) Vibrio sp identified in Specimen by Organism specific culture

547

2598

2.09

55.38

1.6

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

546

2594

2.09

55.24

1.6

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

546

2594

2.09

55.24

1.6

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

900

5052

1.77

55.06

2.5

2.3

204.1

200.8

0.51

849

4762

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

244

801

3.00

54.67

1.1

1.0

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1914

12965

1.48

53.92

8.0

6.7

24.8

mmol/l

0.13

1897

12837

(3036489) Thrombin time

1156

6990

1.65

53.82

2.2

1.9

22.2

21.8

0.73

1044

6179

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

970

5629

1.72

52.75

1.6

1.5

1.2

g/l

0.20

921

5324

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

946

5454

1.73

52.67

1.6

1.5

0.2

g/l

0.16

894

5137

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

543

2624

2.05

52.48

1.5

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

511

2423

2.09

51.98

1.2

1.1

1.6

1.5

g/l

0.76

462

2177

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

552

2695

2.03

51.87

1.5

1.4

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

358

1469

2.41

51.71

1.2

98.0

167.5

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

358

1472

2.40

51.48

1.2

144.0

167.6

titre

0.26

264

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

511

2432

2.08

51.47

3.4

7.0

9.5

nmol/l

0.46

500

2359

(3024522) Salmonella sp identified in Specimen by Organism specific culture

541

2637

2.03

51.07

1.6

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

1555

10234

1.52

50.26

1.4

1.3

220.6

244.6

u/ml

0.29

1423

9408

(3007930) Methemoglobin/Hemoglobin.total in Blood

1423

9217

1.54

49.49

5.5

5.1

0.9

0.01

1355

8637

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

755

4181

1.79

48.35

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1424

9300

1.53

47.65

2.1

2.0

1.8

2.3

ug/l

1.16

1249

8158

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

5665

46170

1.26

47.32

1.8

1.7

34314985.6

29998289.9

pmol/l

0.22

4756

37286

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1432

9379

1.53

47.28

5.4

5.0

1.7

1.6

1.30

1364

8796

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3461

26468

1.33

47.26

5.0

4.8

32.8

32.7

0.13

2457

17433

(3037756) Immunofixation for Serum or Plasma

861

4996

1.71

46.81

1.5

1.6

—

(3049717) Cytology report of Urine Cyto stain

1418

9375

1.51

44.73

2.9

2.8

—

(40760888) Immunoglobulin light chains.free panel - Serum

941

5677

1.65

44.13

2.8

3.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1259

8138

1.54

44.11

1.9

1.8

39.4

38.9

u/l

0.41

1081

7048

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1659

11357

1.46

43.98

1.3

45.8

53.6

au/ml

0.62

484

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1801

12534

1.44

43.74

2.5

2.4

24.3

29.3

au/ml

0.58

541

(3038177) Helicobacter pylori Ab [Presence] in Serum

517

2625

1.95

43.50

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

7343

62034

1.23

43.50

4.9

4.5

22.1

0.09

3822

32010

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

613

3316

1.83

42.43

1.3

—

(3017732) Neutrophils [#/volume] in Blood

1892

13362

1.42

42.32

3.0

3.1

4.2

4.1

e9/l

0.32

1330

9838

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

693

3911

1.76

41.60

6.8

5.2

931.6

1325.3

iu/ml

0.30

124

604

(21494890) Protein electrophoresis panel - 24 hour Urine

481

2423

1.96

41.43

1.8

2.1

—

(3044927) Protein electrophoresis panel - Urine

469

2349

1.97

41.08

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

755

4406

1.70

40.19

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

206

739

2.74

39.37

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

562

3037

1.83

39.05

1.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

403

1958

2.03

38.48

2.2

2.3

—

0.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

266

1102

2.38

37.74

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

264

1091

2.38

37.67

1.3

1.2

—

(4062490)

382

1843

2.05

37.20

1.5

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

526

2830

1.84

37.09

1.2

312.2

284.5

u/ml

1.03

346

1758

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1582

11087

1.42

36.79

3.0

3.3

4.3

4.4

pmol/l

0.90

1367

9783

(40760892) CBC W Ordered Manual Differential panel - Blood

4994

41136

1.24

36.32

5.3

4.6

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

381

1853

2.03

36.30

1.5

1.4

0.4

g/l

0.02

282

1276

(3028192) IgG subclass 2 [Mass/volume] in Serum

381

1854

2.03

36.25

1.5

1.4

2.8

3.0

g/l

0.98

280

1275

(3027135) IgG subclass 1 [Mass/volume] in Serum

381

1855

2.03

36.20

1.5

1.4

6.6

7.0

g/l

1.07

281

1273

(3026250) Tacrolimus [Mass/volume] in Blood

197

722

2.69

36.17

35.6

33.3

7.0

7.2

ug/l

0.46

176

642

(44816559) Phosphatidylethanol [Mass/volume] in Blood

523

2834

1.82

36.04

1.5

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

551

3037

1.79

35.90

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

705

4173

1.67

35.60

1.2

175.7

149.8

titre

0.10

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

205

775

2.60

35.39

2.9

2.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

5320

44230

1.23

35.26

3.2

0.8

ug/l

0.91

3939

30877

(3048929) Epstein Barr virus Ab [Presence] in Serum

682

4016

1.68

35.12

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

847

5267

1.60

35.10

1.7

1.6

15466.2

14314.8

e6/l

0.28

613

3811

(40768443) Skin Pathology biopsy report

1350

9290

1.45

34.64

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

790

4857

1.61

34.32

3.6

3.1

0.8

nmol/l

1.36

627

3754

(3038515) Glucose [Moles/volume] in Venous blood

772

4743

1.61

33.64

4.7

3.4

7.7

7.6

mmol/l

0.39

759

4649

(3008037) Lactate [Moles/volume] in Venous blood

802

5010

1.59

32.60

4.5

3.3

1.6

mmol/l

0.31

790

4900

(3029937) Albumin [Presence] in Urine by Test strip

6342

54048

1.20

32.05

5.4

4.3

0.0

estimate

0.06

1598

17851

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

421

2212

1.88

32.05

3.9

3.6

—

(3042733) HLA Ab [Presence] in Serum

154

529

2.86

32.03

5.7

4.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

851

5423

1.56

31.72

2.5

2.4

119.8

113.0

ug/min

0.19

503

3116

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

585

3402

1.70

31.60

1.6

1.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1601

11543

1.38

31.45

3.2

2.8

0.3

e6/l

0.14

1560

11297

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

907

5887

1.53

31.10

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

529

3013

1.74

30.82

1.6

1.4

116.5

117.8

u/ml

0.10

125

704

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

577

3379

1.69

30.38

1.5

1.4

30.8

18.8

u/ml

1.38

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1062

7168

1.47

30.11

1.2

0.4

1.0

u/ml

3.23

114

654

(1761482) Bacteria [#/volume] in Urine by Culture

910

5961

1.51

29.89

5.3

4.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

369

1901

1.91

29.87

1.1

3.5

3.9

u/ml

0.21

119

730

(40768441) Liver Pathology biopsy report

293

1397

2.07

29.57

1.6

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

392

2067

1.87

29.55

3.4

2.8

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

520

2995

1.72

29.13

7.5

6.0

12.2

12.0

mg/l

0.47

466

2744

(3045414) Leukocytes [Presence] in Urine

1290

9091

1.41

28.95

2.1

1.9

—

(3051611) Lipemic interference index of Serum or Plasma

418

2265

1.82

28.90

3.8

3.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

419

2273

1.82

28.86

1.2

54.1

63.6

u/l

1.92

277

1508

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1881

14088

1.33

28.82

2.4

2.1

11.6

12.3

nmol/l

3.26

1601

12265

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

498

2844

1.73

28.77

1.1

—

(3000330) Specific gravity of Urine by Test strip

1511

10964

1.37

28.47

4.8

3.6

—

(3003694) ABO and Rh group [Type] in Blood

5853

49949

1.19

28.47

1.3

—

(3051651) Icteric interference index of Serum or Plasma

264

1230

2.11

28.34

3.8

3.9

—

(3010375) cycloSPORINE [Mass/volume] in Blood

197

814

2.38

28.26

31.9

28.4

111.5

111.3

ug/l

0.02

160

695

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

778

4995

1.54

28.06

1.6

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

397

2146

1.82

27.68

1.7

1.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

387

2088

1.83

27.16

1.2

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

265

1257

2.08

27.16

1.2

30.5

25.0

u/l

0.65

221

1073

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

270

1291

2.06

27.09

1.2

98.3

90.2

u/l

0.57

230

1128

(3033705) Calcium.ionized [Moles/volume] in Venous blood

491

2845

1.70

26.94

3.0

2.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

376

2016

1.84

26.93

1.8

1.7

—

(3045424) Erythrocytes [Presence] in Urine

564

3420

1.63

25.99

1.6

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

422

2373

1.75

25.80

1.3

1.2

3.7

3.9

u/ml

0.17

194

1052

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

786

5163

1.51

25.50

3.6

2.8

1.9

1.6

mg/l

7.63

727

4650

(3023199) Leukocytes [#/volume] in Pleural fluid

493

2911

1.67

25.23

1.5

1887.2

2988.9

e6/l

1.41

349

2131

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

285

1427

1.97

25.18

1.5

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

289

1456

1.95

25.08

1.5

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

767

5049

1.50

24.64

1.2

1.3

22.5

41.6

u/ml

1.85

299

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

476

2804

1.68

24.59

1.4

1.3

2.4

1.6

nmol/l

0.16

450

2691

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1277

9235

1.37

24.53

2.1

2.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

227

1057

2.11

24.49

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

227

1057

2.11

24.49

1.5

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

241

1149

2.06

24.42

2.4

2.1

17.0

28.0

umol/l

1.06

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

621

3921

1.57

24.18

1.2

1.8

5.5

u/ml

2.67

323

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

221

1025

2.12

24.10

1.5

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

221

1026

2.12

24.04

1.5

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1185

8495

1.38

24.02

1.9

1.8

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

781

5189

1.49

23.99

2.1

1.9

12.6

11.4

mg/l

4.05

721

4780

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

837

5653

1.47

23.67

1.6

1.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

465

2751

1.67

23.65

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

425

2458

1.71

23.54

1.3

1.2

3.0

4.0

u/ml

0.69

145

841

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

521

3182

1.62

23.37

1.9

1.8

180.4

195.1

pmol/l

2.95

476

2975

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

472

2815

1.65

23.28

1.4

1.3

0.2

0.3

nmol/l

0.42

230

(44806118)

388

2196

1.74

23.24

1.6

1.5

—

(44790047)

388

2197

1.74

23.20

1.6

1.5

—

(44790049)

388

2197

1.74

23.20

1.6

1.5

—

(44790048)

388

2197

1.74

23.20

1.6

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

711

4683

1.50

22.80

1.2

1.3

8.5

6.4

u/ml

0.39

772

(3003434) Protein [Mass/volume] in Pleural fluid

533

3293

1.60

22.80

1.6

1.5

31.0

32.6

g/l

2.17

458

2979

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

243

1199

1.99

22.45

1.4

13.8

13.4

umol/l

0.30

229

1129

(3028308) Erythrocytes [#/volume] in Pleural fluid

447

2654

1.66

22.45

1.5

63280.1

57394.9

e6/l

0.13

267

1590

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

702

4628

1.50

22.42

1.2

1.3

2.4

5.5

u/ml

1.92

508

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

672

4397

1.51

22.25

1.8

1.7

42.7

44.0

nmol/l

0.75

644

4232

(3023487) Leukocytes [#/volume] in Peritoneal fluid

176

771

2.24

22.17

2.6

1.8

4001.3

3587.3

e6/l

0.04

129

524

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

492

3007

1.61

22.03

3.2

2.5

714.6

4727.3

u/ml

0.78

190

(3009214) Lutropin [Units/volume] in Serum or Plasma

545

3415

1.58

21.97

1.4

1.3

11.6

11.5

u/l

0.07

443

2741

(3003181) Sodium [Moles/volume] in Urine

616

3969

1.53

21.93

1.4

1.3

60.7

62.5

mmol/l

0.52

489

3176

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1137

8244

1.37

21.48

1.8

1.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2392

19156

1.25

21.44

1.6

—

(21494434) Karyotype in Bone marrow

343

1919

1.76

21.43

1.2

1.1

—

(1002224) Polysomnography panel

875

6073

1.43

21.41

1.1

—

(3036603) Volume of Urine

264

1363

1.91

21.39

1.7

1.6

1877.6

1968.0

0.34

351

(1761868) Lipid panel - Serum or Plasma

5614

61715

0.86

21.19

3.4

3.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

611

3967

1.52

21.01

1.2

11.9

12.4

u/ml

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

234

1168

1.97

20.96

1.1

—

(3006270) Folate [Moles/volume] in Blood

319

1761

1.78

20.88

1.3

1.2

313.4

344.5

nmol/l

1.94

253

1416

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

464

2837

1.61

20.77

2.7

2.0

26.2

27.6

mg/l

0.18

104

770

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

253

1304

1.91

20.63

1.0

1.1

290.5

289.6

mg/l

0.08

219

1161

(3033799) Differential panel - Peritoneal fluid

155

665

2.29

20.56

2.0

1.8

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

430

2593

1.64

20.36

1.4

1.3

—

(3024471) HLA-A [Type]

135

548

2.42

20.30

1.0

—

(3024932) HLA-DR beta [Type]

132

533

2.43

20.09

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

218

1078

1.99

20.08

1.1

—

(3039000) Anion gap in Blood

735

5006

1.45

19.94

7.1

6.8

11.1

11.2

mmol/l

0.49

674

4503

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

218

1081

1.98

19.92

1.1

—

(3018572) Chloride [Moles/volume] in Blood

735

5007

1.45

19.92

7.1

6.8

105.2

105.0

mmol/l

0.68

674

4504

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1023

7397

1.37

19.67

1.8

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

575

3742

1.52

19.59

1.5

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

910

6460

1.39

19.58

1.8

1.7

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

408

2455

1.64

19.51

1.4

1.3

—

nmol/l

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

154

678

2.23

19.24

2.4

1.7

6500.2

12146.3

e6/l

0.64

367

(3023420) DNA double strand Ab [Units/volume] in Serum

325

1852

1.73

19.10

1.5

1.4

21.2

29.7

iu/ml

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

538

3474

1.53

19.02

1.4

1.3

38.1

39.2

u/l

0.07

471

2995

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

235

1220

1.89

18.79

1.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

267

1444

1.82

18.77

1.1

—

(3044941) Cell count panel - Synovial fluid

522

3366

1.53

18.58

1.5

1.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

189

914

2.03

18.57

2.6

1.9

90.7

97.9

1.79

181

853

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

256

3.03

18.44

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

129

537

2.36

18.40

1.8

1.3

13.2

13.7

g/l

0.25

102

408

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

570

3753

1.50

18.39

1.5

—

(3006462) Nitrate [Presence] in Urine

197

971

1.99

18.36

4.4

3.3

—

(3021788) Differential panel - Synovial fluid

601

4007

1.48

18.23

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

111

434

2.51

18.15

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

446

2794

1.57

18.08

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

569

3766

1.49

17.91

1.5

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

266

1461

1.79

17.79

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

348

2067

1.66

17.57

1.4

211987.4

121598.1

e6/l

1.10

246

1409

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

542

3569

1.50

17.50

1.2

36.4

47.1

u/ml

0.74

363

(3012441) Differential panel - Pleural fluid

407

2518

1.59

17.43

1.5

—

(3045788) Cell count panel - Pleural fluid

369

2235

1.63

17.25

1.6

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

198

1000

1.95

17.24

2.4

2.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

270

1504

1.77

17.24

2.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

197

996

1.94

17.11

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

708

4930

1.42

17.07

1.7

1.6

—

(4211845)

206

1059

1.91

17.03

4.3

3.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

6071

53675

1.14

17.01

1.7

1.6

1.4

1.3

mmol/l

6.52

5268

44106

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

614

4177

1.45

16.82

1.1

—

(3017704) Immunofixation for Urine

236

1273

1.82

16.79

1.4

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

640

4395

1.44

16.68

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

195

3.22

16.61

1.6

1.7

53.4

43.5

umol/l

1.15

195

(40768806) Pleura Pathology biopsy report

405

2539

1.57

16.42

1.5

—

(3005570) Glucose [Moles/volume] in Urine

349

2112

1.63

16.40

1.9

—

1.3

—

(40768446) Kidney Pathology biopsy report

150

698

2.11

16.40

1.7

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

580

3924

1.46

16.37

1.9

1.6

0.9

0.8

nmol/l

1.45

481

3245

(3011985) Renin [Units/volume] in Plasma

421

2665

1.56

16.36

1.3

1.4

80.9

58.1

mu/l

0.99

365

2366

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

211

1111

1.87

16.23

2.4

2.5

0.2

e9/l

0.07

189

984

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

305

1789

1.68

16.20

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

370

2280

1.60

16.15

1.2

54.2

57.1

u/ml

0.07

165

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

219

1170

1.84

16.10

2.3

2.4

487.5

539.7

e6/l

0.42

188

990

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

317

1889

1.65

15.86

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

317

1889

1.65

15.86

1.7

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

317

1889

1.65

15.86

1.7

1.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1210

9260

1.29

15.74

3.1

3.9

46.9

68.8

u/ml

2.30

1154

8933

(4094501)

775

5567

1.38

15.59

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

165

812

2.00

15.54

1.0

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

193

1002

1.89

15.53

1.2

1.1

3.0

4.2

iu/ml

0.92

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

722

5133

1.39

15.47

1.6

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

234

1292

1.78

15.46

1.2

1.1

—

(4306422)

377

2359

1.57

15.44

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

455

2968

1.51

15.43

1.2

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

380

2383

1.57

15.42

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

233

1286

1.78

15.41

1.2

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

361

2241

1.59

15.30

1.4

1.3

370.5

495.1

u/l

1.03

337

2131

(3047181) Lactate [Moles/volume] in Blood

939

6969

1.33

15.27

6.6

6.0

1.2

1.3

mmol/l

1.83

838

6168

(3036782) Glucose [Moles/volume] in Pleural fluid

354

2189

1.59

15.26

1.4

6.9

6.3

mmol/l

2.93

320

2040

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

239

1333

1.76

15.26

1.6

1.5

5.0

6.3

u/l

0.70

122

624

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

233

1291

1.77

15.22

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

233

1292

1.77

15.18

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

232

1285

1.78

15.17

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

232

1287

1.77

15.09

1.2

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

123

548

2.20

15.05

1.6

1.9

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

280

1639

1.68

15.03

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

365

2283

1.57

14.99

1.2

1.1

120.3

117.7

0.73

337

2026

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

290

1716

1.66

14.94

1.2

1.1

95.6

94.8

0.18

271

1586

(3019420) Tryptase [Mass/volume] in Serum or Plasma

168

844

1.96

14.93

1.5

1.6

8.7

9.4

ug/l

0.21

159

761

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1341

10478

1.27

14.78

1.2

117.6

137.0

iu/ml

1.13

472

3793

(4268621)

274

1604

1.68

14.71

2.3

—

(3004616) Nuclear Ab [Presence] in Serum

374

2364

1.56

14.68

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

109

467

2.29

14.66

1.8

1.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

442

2898

1.50

14.65

1.9

1.7

—

(3023419) Bacteria identified in Sputum by Culture

435

2854

1.50

14.38

2.7

2.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

140

669

2.06

14.34

1.5

1.8

20350.8

35197.6

u/ml

0.27

100

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

318

1948

1.61

14.29

2.0

1.9

1251.3

3218.5

u/l

1.70

699

(3013005) Retinol [Moles/volume] in Serum or Plasma

133

625

2.09

14.24

1.9

1.5

2.1

2.0

umol/l

0.18

127

580

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

501

3391

1.46

14.17

1.4

—

(3008898) HLA-B27 [Presence]

640

4536

1.39

14.01

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

386

2493

1.52

13.78

1.3

297.8

276.1

pmol/l

0.48

312

1902

(3017181) Myelocytes/100 leukocytes in Blood

2154

17858

1.20

13.49

4.4

4.0

1.0

0.22

695

5303

(3002331) Protein [Mass/volume] in Peritoneal fluid

108

484

2.19

13.10

1.4

25.6

41.3

g/l

0.69

381

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

174

926

1.85

13.06

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

483

3312

1.44

12.80

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

197

1096

1.77

12.78

2.2

102.4

108.9

ug/min

0.05

252

(3020876) Protein [Mass/time] in 24 hour Urine

310

1942

1.57

12.73

1.8

1.9

0.6

1.0

g/24h

0.76

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

279

1713

1.60

12.49

1.5

1.4

13.5

13.0

u/l

0.66

272

1644

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

225

1308

1.69

12.49

2.3

2.4

635.3

703.1

e6/l

0.30

102

535

(3020717) Zinc [Moles/volume] in Serum or Plasma

152

787

1.90

12.45

1.6

1.4

22.3

25.7

umol/l

0.70

147

740

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

107

488

2.15

12.45

1.2

339.7

282.9

pmol/l

0.37

348

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

318

2016

1.55

12.41

1.4

1.3

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

445

3026

1.45

12.35

1.7

1.9

26.4

24.0

ug/l

0.23

436

2957

(3035637) Corticotropin [Mass/volume] in Plasma

358

2334

1.51

12.28

1.4

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

372

2445

1.50

12.28

3.9

3.8

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

115

545

2.07

12.13

1.2

0.3

g/l

0.12

440

(3044007) Cell count panel - Peritoneal fluid

126

619

2.00

12.05

2.3

1.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

446

3053

1.44

11.96

1.5

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

175

961

1.79

11.90

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

264

1620

1.60

11.88

1.5

1.3

32.1

34.2

u/l

0.43

210

1313

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

522

3681

1.40

11.84

2.1

1.7

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

397

2.25

11.83

3.1

2.9

6.8

7.2

mg/l

0.22

312

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

534

3788

1.39

11.70

1.7

1.6

—

(4146454)

384

2571

1.47

11.59

2.9

2.7

—

(3003129) Base excess in Capillary blood by calculation

117

569

2.02

11.53

2.1

1.7

0.3

0.5

mmol/l

0.17

108

540

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

136

699

1.91

11.43

1.9

1.4

27.4

30.0

umol/l

1.82

131

669

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

283

1783

1.56

11.40

1.4

1.3

10.7

13.8

u/l

2.39

263

1649

(3022493) Free Hemoglobin [Mass/volume] in Plasma

159

860

1.82

11.40

8.6

3.6

1115.5

1033.7

mg/l

0.03

121

596

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

368

2.27

11.27

2.5

2.3

117.9

185.7

au/ml

0.61

(3001186) Copper [Moles/volume] in Serum or Plasma

387

2.23

11.25

1.3

1.2

17.0

16.6

umol/l

0.42

345

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

449

3114

1.42

11.24

1.3

220.0

211.2

miu/ml

0.17

163

1214

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

107

509

2.06

11.21

1.2

111.0

113.0

0.25

451

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

460

3206

1.41

11.20

1.1

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

239

1456

1.61

11.11

2.5

—

(3051593) INR in Capillary blood by Coagulation assay

202

1179

1.68

11.11

9.2

10.8

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

274

1728

1.56

11.01

1.6

21.9

25.8

u/ml

1.02

362

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

236

2.58

10.90

4.9

4.8

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

207

1223

1.66

10.88

1.8

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

196

1142

1.69

10.86

3.0

1.8

17.9

15.8

nmol/l

3.15

190

1057

(3004775) Volume in Urine collected for unspecified duration

289

1852

1.53

10.81

2.6

2.2

715.7

676.7

0.77

198

1221

(3028433) Virus identified in Specimen by Culture

128

659

1.91

10.74

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

283

1809

1.54

10.71

1.4

1.3

1.5

1.4

nmol/l

1.36

260

1632

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

214

1284

1.64

10.61

2.0

1.9

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

100

474

2.07

10.60

2.6

2.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

309

2019

1.51

10.57

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

151

824

1.80

10.55

2.9

2.5

—

(21494755) Public health laboratory ask at order entry panel

901

11052

0.79

10.54

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

325

2151

1.49

10.45

1.1

0.9

1.2

u/ml

0.32

127

801

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

589

4325

1.34

10.43

1.7

5.0

8.7

iu/l

0.65

158

1463

(3018133) Calcium [Moles/volume] in Urine

226

2.56

10.27

1.2

1.6

2.2

2.7

mmol/l

1.18

194

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

231

1426

1.59

10.21

1.3

53.6

77.1

titre

0.57

122

(3025159) Blasts/100 leukocytes in Blood

1888

15864

1.18

10.10

4.4

4.1

0.1

0.3

3.35

548

4154

(3016244) Insulin [Units/volume] in Serum or Plasma

138

743

1.82

10.10

2.5

3.1

28.0

24.2

mu/l

0.45

131

691

(3047189) Immunofixation for 24 hour Urine

184

1076

1.68

10.10

1.5

1.7

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

182

1062

1.68

10.07

2.8

39.0

37.8

0.23

362

(3019832) Treponema pallidum Ab [Presence] in Serum

889

6933

1.27

10.04

1.5

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

185

1087

1.67

9.98

1.2

390.2

331.4

u/l

0.13

168

1011

(3034274) Bile acid [Moles/volume] in Serum --fasting

166

950

1.72

9.88

1.5

7.6

11.9

umol/l

1.86

122

676

(3017354) Segmented neutrophils/100 leukocytes in Blood

338

2285

1.45

9.79

3.3

3.4

58.9

59.2

0.08

249

1429

(3021387) Prolactin [Units/volume] in Serum or Plasma

481

3465

1.37

9.68

1.8

1.7

279.5

307.5

mu/l

0.97

446

3171

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

278

1813

1.51

9.64

1.1

1.2

—

(3011412) CD3 cells [#/volume] in Blood

271

1760

1.51

9.59

2.3

1.1

e9/l

0.16

142

1089

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

187

1114

1.65

9.59

1.6

1.5

6.4

6.1

u/l

0.15

149

931

(3020491) Glucose [Moles/volume] in Blood

227

1418

1.57

9.58

1.6

2.0

7.3

7.2

mmol/l

0.11

145

988

(3015235) Bicarbonate [Moles/volume] in Capillary blood

752

5781

1.28

9.57

3.3

3.1

24.4

24.9

mmol/l

2.52

671

5057

(37021550) Renin [Units/volume] in Plasma --upright

421

2.07

9.54

1.2

1.3

89.7

65.8

mu/l

0.41

302

(44813793)

192

1157

1.63

9.42

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

233

1472

1.56

9.37

1.3

139.4

457.6

titre

2.27

132

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

111

3.18

9.32

1.4

1.2

52.9

43.9

mg/l

1.01

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

141

784

1.77

9.31

2.2

1.9

50.8

56.4

ug/l

0.53

141

760

(3021440) Promyelocytes/100 leukocytes in Blood

1998

16977

1.17

9.30

4.5

4.0

0.1

0.01

620

4942

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

398

2800

1.40

9.27

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

416

2950

1.39

9.24

1.4

—

(3023383) Lactate [Moles/volume] in Pleural fluid

135

744

1.78

9.20

1.5

1.3

3.5

3.4

mmol/l

0.13

125

681

(3003888) Timothy IgE Ab [Units/volume] in Serum

286

1896

1.48

9.18

1.0

1.1

2.9

3.5

u/ml

0.48

139

862

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

256

1661

1.51

9.13

1.9

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2638

22948

1.14

8.84

1.4

—

(40761536) Microorganisms panel - Urine sediment

1514

17334

0.85

8.84

5.3

4.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

276

1833

1.48

8.81

1.0

1.1

0.8

1.1

u/ml

0.75

109

706

(3004809) Band form neutrophils/100 leukocytes in Blood

501

3689

1.34

8.78

3.4

1.5

0.04

407

2830

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

109

571

1.87

8.77

1.5

1.4

19.3

22.1

0.57

481

(3014271) Vancomycin [Susceptibility]

209

1309

1.57

8.76

3.1

3.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

198

1227

1.58

8.70

1.5

1.3

1.2

1.4

u/ml

0.11

118

629

(3016038) Potassium [Moles/volume] in Urine

225

1437

1.54

8.66

1.2

1.1

34.0

34.6

mmol/l

0.14

197

1206

(3045142) Bone marrow Pathology biopsy report

353

2464

1.41

8.64

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

605

4588

1.30

8.60

1.3

573.8

564.8

mg/l

0.07

569

4352

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

288

1942

1.46

8.52

1.1

2.3

2.0

iu/ml

—

(3006245) CD3-CD19+ cells/100 cells in Blood

108

571

1.86

8.46

2.2

2.0

10.1

10.8

0.20

513

(3002179) Metamyelocytes/100 leukocytes in Blood

1899

16193

1.16

8.44

4.0

3.9

0.7

0.28

513

3799

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

101

523

1.89

8.44

1.1

—

(4015189)

118

644

1.80

8.35

2.3

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

302

2066

1.44

8.29

2.3

2.0

2.9

titre

0.48

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

537

4034

1.31

8.21

1.2

1.3

3.9

3.8

mmol/l

0.39

497

3789

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

240

1573

1.50

8.21

1.2

93.1

83.4

u/ml

—

(3038026) Centromere Ab [Units/volume] in Serum

246

1622

1.49

8.17

1.2

50.7

51.2

u/ml

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

230

1498

1.51

8.11

1.2

2.3

7.6

u/ml

1.53

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

240

1578

1.49

8.09

1.2

54.0

42.3

u/ml

0.24

125

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

182

2.53

8.09

2.4

2.0

55.7

60.5

0.34

115

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

108

580

1.83

8.07

2.1

1.9

28.1

30.4

0.89

102

539

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

106

566

1.84

8.07

2.6

2.9

—

(3036670) Protein [Mass/volume] in Synovial fluid

125

702

1.75

8.05

1.2

1.3

39.5

40.0

g/l

0.15

361

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

330

2311

1.40

7.97

1.1

7.7

12.5

au/ml

—

100

(40762365) Oxygen content in Arterial blood by calculation

384

2.02

7.95

4.1

2.8

14.5

14.8

ml/dl

0.29

356

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

103

549

1.84

7.90

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

372

2664

1.37

7.86

4.9

4.6

351.9

355.9

umol/l

0.21

322

2257

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

140

2.73

7.80

2.3

1.9

19.9

16.9

0.18

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

116

644

1.77

7.79

1.3

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

498

1.87

7.69

1.3

1.2

—

(3023410) Appearance of Cerebral spinal fluid

259

1751

1.45

7.62

1.7

1.5

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

3.62

7.61

1.0

36.4

38.0

u/ml

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

121

2.84

7.51

2.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

145

869

1.64

7.38

1.4

61.5

64.0

0.37

120

709

(3020191) Ethanol [Moles/volume] in Serum or Plasma

216

1424

1.49

7.24

1.4

1.3

promille

0.08

167

1076

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

235

2.25

7.23

2.0

2.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

121

696

1.71

7.21

1.5

2.1

164.7

165.5

0.04

111

641

(4212803)

205

2.34

7.19

1.0

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

491

3721

1.30

7.10

1.4

1.3

—

(4281824)

309

2192

1.39

6.98

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

230

1550

1.46

6.93

4.3

5.0

55.9

125.5

u/ml

1.80

446

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

254

1745

1.43

6.90

1.8

3.7

4.1

mg/l

0.97

239

1656

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

259

2.16

6.90

1.2

1.3

130959.0

229816.3

nmol/l

0.24

208

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

374

2741

1.34

6.88

1.1

82.7

4368.8

iu/ml

0.56

560

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

546

1.78

6.86

1.2

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

642

5059

1.25

6.77

1.3

—

(44806420)

116

672

1.69

6.76

2.5

2.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

399

2968

1.32

6.64

1.6

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

146

902

1.59

6.62

1.9

—

(3000034) Microalbumin [Mass/volume] in Urine

284

2006

1.39

6.61

3.7

3.0

68.5

44.4

mg/l

0.58

207

1443

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

245

2.16

6.58

2.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

219

1481

1.45

6.51

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

493

3785

1.28

6.49

3.8

3.2

—

(3022621) pH of Urine by Test strip

1590

13653

1.15

6.46

3.7

3.0

—

(3016750) Collection duration of Urine

200

1331

1.48

6.46

2.5

2.1

492.9

501.4

min

0.70

161

948

(3020393) Adenovirus Ag [Presence] in Stool

179

2.35

6.42

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

112

653

1.68

6.40

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

103

588

1.72

6.36

1.4

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

136

838

1.59

6.26

1.3

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

117

2.68

6.24

1.4

14.9

18.3

pmol/l

0.58

(3000060) B lymphocytes [#/volume] in Blood

378

1.89

6.22

2.0

1.9

2446.5

1192.1

e6/l

0.27

200

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

292

2.01

6.12

1.2

—

(1616796) Gas panel - Central venous blood

636

5072

1.23

6.06

4.3

3.7

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

320

1.96

6.06

1.3

1.2

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

3.37

6.05

1.0

1.1

166.4

193.9

ug/g

0.19

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

335

1.93

5.99

2.2

1.7

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

126

775

1.60

5.88

1.5

1.6

2.9

7.8

nmol/l

0.92

105

655

(3006184) Hemoglobin [Mass/volume] in Capillary blood

653

5242

1.23

5.86

2.4

2.2

125.5

128.5

g/l

1.91

431

3800

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

315

2310

1.34

5.85

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

264

2.04

5.84

2.4

2.0

—

(3016018) Differential panel - Cerebral spinal fluid

271

1942

1.37

5.84

1.5

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

106

626

1.66

5.82

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

501

1.74

5.82

1.1

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

174

1152

1.48

5.82

1.1

1.2

51.4

44.0

mg/l

0.72

159

957

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

213

2.16

5.79

1.0

—

(3035880) pH of Pleural fluid

199

1354

1.44

5.78

1.4

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

310

2272

1.34

5.78

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

141

894

1.55

5.78

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

141

894

1.55

5.78

1.9

—

(3025130) Human papilloma virus identified in Specimen

235

1648

1.40

5.77

1.7

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

333

1.91

5.75

1.7

1.5

106.0

111.3

ug/l

0.16

273

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

306

1.95

5.74

1.3

1.2

1450.3

141.0

ng/l

0.46

210

(3037692) Legionella sp identified in Specimen by Organism specific culture

126

780

1.58

5.73

1.6

1.4

—

(1175426) CD3 cells/100 lymphocytes in Blood

200

1367

1.44

5.68

2.1

1.9

70.1

71.8

0.83

189

1300

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

169

1119

1.48

5.66

1.2

1.1

95.4

85.4

u/l

0.80

147

863

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

208

1433

1.42

5.66

1.4

0.3

nmol/l

0.40

153

1020

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

371

2799

1.30

5.65

1.6

1.5

58.7

59.9

0.24

260

1747

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

169

1120

1.48

5.64

1.2

1.1

30.4

25.1

u/l

0.55

143

829

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

160

1051

1.49

5.58

1.0

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

252

1802

1.37

5.53

1.8

1.7

1344.0

2071.8

titre

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

155

1014

1.50

5.52

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

166

1103

1.48

5.48

1.5

1.3

1.2

nmol/l

0.24

124

847

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

195

1339

1.43

5.42

2.1

1.9

16.0

15.2

0.34

520

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

148

963

1.51

5.42

1.1

10.5

9.8

iu/ml

0.10

210

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

509

4016

1.25

5.40

1.4

19.4

29.3

e6/l

0.72

399

3117

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

158

1043

1.49

5.39

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

509

4021

1.24

5.35

1.5

1.4

5595.0

1485.1

e6/l

0.47

415

3288

(3041672) Baker's yeast Ab [Presence] in Serum

3.27

5.24

1.1

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

164

1098

1.47

5.23

1.1

344.4

293.9

mg/l

0.91

151

949

(3041096) Erythrocytes [Presence] in Urine by Automated

5539

51241

1.08

5.23

4.4

3.6

—

(3042631) Mycobacterium sp identified in Specimen

424

3293

1.27

5.18

2.8

2.6

—

(3006576) Bicarbonate [Moles/volume] in Blood

125

793

1.55

5.16

6.9

6.4

25.0

25.1

mmol/l

0.07

113

712

(3036071) Salmonella sp Ab [Titer] in Serum

469

1.71

5.12

1.1

—

(3024263) Appearance of Synovial fluid

168

1142

1.44

4.98

1.5

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

386

1.78

4.97

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

171

1167

1.44

4.96

1.8

1.6

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

102

625

1.60

4.91

1.5

16.2

16.1

pmol/l

0.04

513

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

477

3783

1.24

4.88

1.4

150.9

181.8

pmol/l

0.87

463

3686

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

158

2.23

4.85

1.2

1.3

1.2

0.9

ml/s/173m2

0.70

100

(4024509)

283

2107

1.32

4.82

1.6

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

298

1.88

4.81

1.5

1.8

62.1

57.7

pmol/l

0.11

246

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

163

1111

1.44

4.78

1.1

1.9

7.3

nmol/l

2.27

219

(21494815) CD4 cells/100 lymphocytes in Specimen

217

1555

1.37

4.77

2.0

2.1

40.3

39.5

0.08

190

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

659

7664

0.84

4.75

1.5

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

578

1.61

4.72

7.4

5.6

63.0

70.6

1.92

470

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

140

929

1.48

4.72

1.2

1.1

—

(3048879) Bone marrow aspiration report

110

696

1.55

4.64

1.6

1.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

125

816

1.50

4.58

1.2

1.1

1.2

1.1

u/l

0.35

397

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1148

9890

1.14

4.54

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

256

1.91

4.52

1.4

—

(3008295) Osmolality of Serum or Plasma

279

2098

1.31

4.46

1.4

1.3

278.7

277.1

mosm/kgh2o

0.45

201

1616

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

210

1515

1.36

4.45

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.14

4.44

1.4

1.3

—

(3049242) von Willebrand panel - Platelet poor plasma

3.14

4.44

1.4

1.9

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

550

1.60

4.42

1.6

1.5

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

438

1.68

4.40

1.7

1.8

9.3

9.1

mg/l

0.14

347

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

225

1.96

4.37

1.2

78.8

115.9

ug/l

1.15

139

(3009015) Lactate [Moles/volume] in Synovial fluid

246

1.91

4.34

1.3

6.2

6.5

mmol/l

0.11

117

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

104

2.45

4.33

1.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

290

2202

1.29

4.32

1.3

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

153

1054

1.42

4.28

1.7

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

182

1294

1.38

4.25

2.1

2.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

444

1.66

4.20

1.1

0.7

umol/24h

0.64

205

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

120

794

1.48

4.16

1.2

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

101

2.43

4.09

4.4

3.2

—

(3026480) Teichoate Ab [Titer] in Serum

190

2.01

4.09

1.2

1.0

—

2.0

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

531

1.59

4.08

1.2

1.3

3.1

umol/l

0.02

486

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

115

758

1.49

4.07

12.4

12.5

0.6

mmol/l

0.24

106

690

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

509

1.60

4.06

1.9

1.6

9.4

9.3

ug/l

0.06

509

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

316

1.77

4.05

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

494

1.61

4.05

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

145

2.16

4.04

1.2

0.3

0.2

nmol/l

0.29

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

198

1440

1.35

4.03

1.2

1.3

2.1

2.2

mmol/l

1.01

181

1333

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

145

1006

1.41

3.94

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

319

1.75

3.94

1.3

19.3

24.9

0.79

245

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

269

1.82

3.93

2.2

2.5

78.1

76.7

pmol/l

0.03

237

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

133

910

1.43

3.90

1.2

1.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

320

1.75

3.90

1.1

1.2

79.3

82.0

0.17

104

(3028717) Thiamine [Mass/volume] in Blood

187

1.99

3.89

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

105

687

1.50

3.87

1.4

23.1

19.9

0.55

616

(40765096) Chromosome analysis panel by Banding

625

1.52

3.85

1.2

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

166

1184

1.38

3.84

1.9

3.3

2.6

u/field

0.36

109

813

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

456

1.61

3.82

1.3

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

249

1887

1.30

3.82

1.5

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.61

3.81

1.4

1.3

141.6

123.2

ug/l

0.13

(3025018) Bordetella pertussis Ab [Titer] in Serum

127

867

1.44

3.79

1.4

1.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

203

1.93

3.77

1.3

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

489

1.58

3.75

1.1

—

(3034426) Prothrombin time (PT)

546

1.54

3.67

1.3

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

492

1.57

3.66

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

320

1.72

3.63

1.2

74.5

73.9

0.04

102

(3001893) Eosinophils/100 leukocytes in Pleural fluid

113

762

1.45

3.61

1.5

1.4

2.4

2.7

0.16

635

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

108

723

1.46

3.59

1.3

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

214

1.88

3.57

2.0

1.7

—

(3010503) CD19 cells [#/volume] in Blood

167

1209

1.36

3.56

2.4

0.1

0.4

e9/l

2.04

160

1165

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

300

1.73

3.56

3.0

2.5

114.3

71.2

mg/l

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.45

3.54

1.0

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

167

1.99

3.53

1.1

0.7

0.5

u/ml

0.10

106

(43055514) Macroprolactin [Presence] in Serum or Plasma

222

1.85

3.53

1.7

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

195

1.91

3.49

1.6

1.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

396

4676

0.83

3.49

4.5

3.5

28.5

28.1

mg/l

0.07

246

2993

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

407

1.61

3.46

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

105

706

1.46

3.43

1.3

344.7

258.2

ug/l

0.16

382

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

455

1.57

3.40

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

268

1.76

3.39

2.9

0.6

0.5

u/field

0.06

268

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

130

2.11

3.38

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

511

1.53

3.35

1.6

1.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

496

1.54

3.34

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

322

1.67

3.30

1.1

1.0

0.7

0.8

u/ml

0.06

154

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

242

1.78

3.28

1.2

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1099

11969

0.89

3.25

1.9

1.8

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.03

3.24

1.5

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

131

928

1.38

3.23

1.2

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

485

1.54

3.22

1.1

81.6

86.8

0.78

237

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

295

1.69

3.20

1.0

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

560

4709

1.17

3.20

2.6

2.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

151

1097

1.35

3.19

3.8

3.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

593

5016

1.16

3.15

3.1

2.9

7.9

kpa

0.58

559

4626

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

472

1.54

3.15

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

108

2.18

3.15

1.1

—

(3017569) Oxygen content in Arterial blood

149

1083

1.35

3.14

2.4

2.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.61

3.09

1.1

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

420

1.56

3.08

1.9

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

158

1164

1.33

3.06

1.9

1.8

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

476

1.52

3.04

1.1

82.7

86.4

0.32

236

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

241

1.75

3.04

1.1

14.9

19.7

u/l

1.34

162

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

227

1.77

3.02

2.0

1.9

15.9

17.6

umol/l

0.61

227

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

157

1162

1.33

2.96

1.9

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

157

1162

1.33

2.96

1.9

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

157

1162

1.33

2.96

1.9

1.8

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

371

1.59

2.94

1.4

11.7

10.3

0.18

184

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

552

1.47

2.93

10.1

7.9

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

372

1.58

2.91

1.1

1.7

3.7

pmol/l

—

(4027681)

118

839

1.38

2.89

1.2

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

171

1286

1.30

2.89

2.2

2.6

—

(3025315) Body weight

181

1.84

2.85

5.8

4.8

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

113

2.08

2.84

1.2

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

213

1652

1.26

2.83

1.1

1.4

1.3

u/ml

0.06

374

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

107

752

1.40

2.82

1.1

615.0

770.0

ng/l

0.17

198

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

114

2.06

2.78

5.1

4.6

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

471

1.50

2.77

10.4

7.7

—

(3020874) Milk IgE Ab [Units/volume] in Serum

648

1.42

2.77

1.1

1.0

1.7

1.0

u/ml

0.27

190

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

640

1.42

2.77

1.1

1631.4

1524.0

miu/ml

0.40

640

(3027874) Urate [Moles/volume] in Urine

2.38

2.74

1.2

1.0

1.6

1.7

mmol/l

0.15

(3013166) Neutrophils/100 leukocytes in Synovial fluid

674

1.41

2.74

1.4

57.1

57.8

0.06

579

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

4.35

2.74

1.5

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

279

1.65

2.73

1.0

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2445

22473

1.07

2.73

3.9

3.6

—

(3011288) Drugs identified in Urine by Screen method

226

1774

1.25

2.73

2.4

3.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.20

2.72

1.9

1.5

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

163

1.86

2.72

1.1

1.2

34.8

24.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

526

4472

1.16

2.67

1.4

1.3

30.4

35.0

iu/l

2.43

446

3843

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

444

1.50

2.66

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

282

1.63

2.64

6.4

5.0

55.9

50.2

ug/min

0.28

231

(3052592) Norovirus Ag [Presence] in Stool

453

1.49

2.63

1.6

1.3

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

533

1.45

2.63

1.4

1.6

0.4

ug/l

0.27

333

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

111

797

1.37

2.60

1.1

2.4

6.0

u/ml

2.24

113

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

224

1.71

2.58

1.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

126

925

1.34

2.56

1.1

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

103

734

1.38

2.54

1.2

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

104

745

1.37

2.49

15.5

16.2

1294.0

1466.0

nmol/l

1.44

713

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

151

1146

1.29

2.44

5.9

6.3

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.67

2.44

3.2

3.7

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

526

1.43

2.43

1.4

1.3

96.7

134.7

nmol/l

2.41

376

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

114

1.98

2.41

1.0

1.4

—

(3021901) Oxygen saturation in Capillary blood

506

4327

1.15

2.41

3.2

2.9

—

(40765089) Chromosome analysis panel - Blood by G-banded

163

1.80

2.41

1.1

1.0

—

(4198724)

391

1.50

2.40

1.7

2.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

227

1814

1.23

2.38

2.0

2.1

3.0

2.2

u/field

0.70

699

(3014599) Egg white IgE Ab [Units/volume] in Serum

627

1.39

2.37

1.0

2.1

0.6

u/ml

0.57

141

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

353

1.53

2.36

1.5

1.6

63.3

82.5

au/ml

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

180

1404

1.26

2.35

1.3

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

223

1.67

2.35

1.1

—

(3002619) Bacteria identified in Specimen by Culture

433

1.47

2.34

1.2

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

109

1.98

2.32

1.1

1.0

—

(3004451) EKG impression Narrative

154

1184

1.28

2.28

1.2

1.3

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

493

1.43

2.27

1.1

1.2

109.3

104.8

0.34

445

(40762887) Creatinine [Moles/volume] in Blood

2.56

2.26

1.3

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

167

1.76

2.24

1.1

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

2.02

2.24

1.0

—

(3014891) Appearance of Pleural fluid

327

1.53

2.22

1.7

1.6

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

146

1.81

2.22

1.1

9.7

11.1

u/l

0.15

146

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

107

788

1.33

2.19

1.7

79.8

114.3

umol/l

1.41

418

(40757373) Influenza virus identified in Isolate

433

1.45

2.16

1.9

1.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

184

1.70

2.15

1.1

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.29

2.11

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.94

2.09

1.2

1.1

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

2.40

2.01

2.3

1.2

0.5

0.3

0.52

(3042301) Urate [Moles/volume] in Synovial fluid

2.51

2.00

1.0

245.3

398.6

umol/l

—

(3011897) Casein IgE Ab [Units/volume] in Serum

137

1.79

2.00

1.2

1.1

0.7

2.1

u/ml

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

707

1.33

1.99

12.0

11.6

772.0

843.5

nmol/l

0.75

672

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.21

1.97

1.0

—

(3015183) Erythrocyte sedimentation rate

658

1.34

1.97

1.4

1.2

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

371

1.45

1.92

2.6

5.3

50.7

54.2

u/l

0.09

142

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

550

4820

1.12

1.87

1.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

222

1822

1.19

1.86

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

295

1.49

1.82

1.7

2.5

—

(3010421) pH of Blood

670

5945

1.11

1.82

5.3

4.0

7.4

0.99

551

5102

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

175

1407

1.22

1.82

1.2

12.1

11.9

mmol/l

0.11

423

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

113

1.82

1.80

1.2

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

103

780

1.29

1.79

2.4

2.3

61.4

55.7

umol/l

0.88

615

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.11

1.78

1.1

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

180

1.63

1.77

1.1

1.0

—

(3025577) Chromium [Mass/volume] in Blood

189

1536

1.21

1.77

2.0

2.1

2.3

ug/l

0.06

154

1280

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1787

18524

0.94

1.76

4.8

3.9

1.2

mmol/l

1.35

1620

16061

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.52

1.75

1.0

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

129

1.75

1.73

1.2

1.3

—

19339.8

—

(3044242) Glucose [Moles/volume] in Arterial blood

141

1116

1.24

1.72

2.3

1.9

—

(3002523) Influenza virus A Ag [Presence] in Specimen

220

1820

1.19

1.71

1.1

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

137

1.72

1.71

1.2

1.6

0.7

0.8

umol/l

0.18

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

251

2100

1.17

1.71

1.6

1.5

25.1

28.7

1.07

169

1280

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

1.88

1.69

1.7

1.5

5.6

3.2

mg/l

0.63

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.88

1.69

2.0

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

727

1.29

1.69

2.6

3.0

29.7

28.5

umol/l

0.52

553

(3010838) Calcium [Moles/time] in 24 hour Urine

136

1075

1.24

1.68

1.6

8.1

5.5

mmol/24h

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

122

953

1.25

1.68

1.2

1.1

ratio

1.11

338

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

222

1.54

1.67

1.1

—

(3022229) Phosphate [Moles/volume] in Urine

2.18

1.65

1.2

1.1

14.3

16.8

mmol/l

0.31

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

1.93

1.65

2.2

2.0

1.7

2.3

mg/l

0.90

(3024869) Neuronal Ab [Presence] in Serum

417

1.39

1.64

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

352

1.42

1.63

1.5

1.2

0.3

1.5

mmol/l

3.71

229

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.96

1.60

1.2

1.1

210.0

294.6

nmol/l

1.91

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.14

1.59

1.2

1.4

229.9

558.4

nmol/l

3.31

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

692

0.72

1.55

1.3

1.4

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

195

1.56

1.55

1.2

—

1.0

mmol/l

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

172

1.59

1.54

1.1

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.94

1.54

1.2

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

601

1.30

1.52

2.0

2.1

53.3

37.2

u/l

0.28

553

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

567

1.31

1.52

1.4

1.8

11.2

4.1

ug/l

0.43

376

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1012

0.77

1.52

1.1

—

(3017509) Phencyclidine [Presence] in Urine

1.80

1.51

1.7

1.3

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.83

1.51

1.4

1.6

0.4

0.2

u/l

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

317

1.42

1.50

1.6

1.2

759.5

168.3

u/l

0.37

227

(3023430) Cat dander IgE Ab [Units/volume] in Serum

164

1342

1.20

1.48

1.1

1.0

2.7

2.8

u/ml

0.04

488

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

151

1.62

1.48

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

121

1.70

1.47

1.3

1.1

13.2

14.6

nmol/l

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.54

1.47

1.4

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.54

1.47

3.0

2.3

1.4

1.9

mu/l

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

302

1.43

1.47

1.8

1.4

67.9

73.0

0.54

254

(3033942) Copper [Moles/time] in 24 hour Urine

2.06

1.47

1.1

0.2

0.7

umol/24h

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

295

1.43

1.45

1.2

—

(3027944) Amphetamines [Presence] in Urine

312

2692

1.14

1.44

1.8

1.9

—

(3016879) Cocaine [Presence] in Urine

298

2564

1.14

1.44

1.8

2.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.79

1.42

5.5

8.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

208

1.51

1.41

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

161

1.58

1.41

1.1

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

3.06

1.40

1.0

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

670

1.27

1.40

1.2

1.4

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.67

1.40

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.67

1.40

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.67

1.40

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.67

1.40

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.67

1.40

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.67

1.40

2.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.18

1.39

6.6

9.3

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

185

1.54

1.39

1.1

1.0

99.9

81.2

ug/l

0.89

134

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

131

1.65

1.39

1.1

1.0

0.2

0.8

u/ml

0.41

(3026470) Cobalt [Mass/volume] in Blood

190

1587

1.17

1.38

2.0

4.3

3.8

ug/l

0.34

170

1389

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

298

1.41

1.38

1.2

1.3

62.2

48.4

0.90

132

(1001926) Buprenorphine [Presence] in Urine by Screen method

247

2106

1.15

1.38

1.8

2.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

282

1.42

1.37

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.07

1.37

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

147

1.60

1.36

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

234

1.47

1.36

1.2

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.88

1.35

1.0

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

2.36

1.35

1.0

1.1

1714.3

1950.3

titre

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.36

1.35

2.4

4.6

—

(3000764) Benzodiazepines [Presence] in Urine

316

2745

1.13

1.34

1.8

2.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

183

1529

1.17

1.34

1.0

287.6

332.3

ng/l

1.72

128

1046

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

562

1.29

1.34

1.5

1.3

37.1

35.9

0.10

373

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

142

1.59

1.28

6.5

4.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

130

0.45

1.27

1.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

183

1537

1.17

1.27

1.0

736.8

715.4

ng/l

0.23

126

1013

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.72

1.26

1.0

1.2

820.7

2769.5

ng/l

3.74

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

2.72

1.25

1.4

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.72

1.25

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

296

1.39

1.25

1.1

1.2

—

(3022475) Manganese [Moles/volume] in Blood

105

1.68

1.24

1.2

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

517

1.29

1.24

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

183

1541

1.16

1.24

1.0

41.3

42.8

ng/l

0.14

126

1036

(3028300) Cannabinoids [Presence] in Urine

317

2772

1.12

1.23

1.8

2.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

381

1.34

1.23

1.1

1.2

—

(3027008) Opiates [Presence] in Urine

316

2766

1.12

1.21

1.8

1.9

—

(3050794) Legionella sp Ab [Presence] in Serum

184

1.49

1.20

1.0

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.12

1.19

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

115

1.62

1.16

1.5

1.2

—

(3013762) Body weight Measured

2.00

1.15

1.0

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

244

2112

1.13

1.14

1.2

7.4

7.7

mmol/l

0.47

179

1511

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

568

1.26

1.13

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

124

1.58

1.11

1.1

1.2

—

(3027315) Oxygen [Partial pressure] in Blood

579

5247

1.08

1.11

5.6

4.1

8.3

8.5

kpa

1.13

562

5122

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

693

1.23

1.10

3.0

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

693

1.23

1.10

3.0

2.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

133

1.55

1.08

1.1

1.0

—

(3019977) pH of Arterial blood

154

1298

1.16

1.07

3.1

2.5

7.4

1.35

467

(3040151) Glucose [Moles/volume] in Capillary blood

297

2614

1.11

1.07

6.3

10.1

7.5

mmol/l

0.04

226

2157

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

118

1.58

1.06

1.1

34.9

106.9

u/l

0.64

(21494567) Legionella sp IgM Ab [Presence] in Serum

150

1.50

1.05

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

375

1.31

1.04

7.3

7.2

—

(40762814) Titanium [Mass/volume] in Blood

444

1.28

1.04

2.3

2.2

2.9

3.5

ug/l

1.35

154

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

119

1.56

1.03

1.1

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

325

1.33

1.02

1.4

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

169

1442

1.15

1.01

1.1

1.0

2.3

3.0

u/ml

0.33

533

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

366

3269

1.10

1.01

3.0

3.5

35.8

40.7

u/ml

0.17

356

3161

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

378

1.30

1.00

1.3

1.8

2.4

ug/l

1.29

220

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

152

1.48

0.99

1.2

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

103

847

1.19

0.98

1.2

63.7

58.6

0.19

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

154

0.57

0.98

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

661

6058

1.07

0.97

1.6

1.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

227

1.38

0.97

1.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

137

1.50

0.97

1.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.80

0.96

1.1

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

146

1.48

0.94

2.4

1.7

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.61

0.93

1.1

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

107

1.56

0.92

1.4

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

230

1.36

0.91

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.10

0.90

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

148

1.46

0.89

1.0

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

153

0.58

0.87

1.4

1.2

—

(3000285) Sodium [Moles/volume] in Blood

300

1.31

0.87

1.1

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.58

0.87

1.2

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

236

0.66

0.86

1.9

2.4

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

141

1.46

0.86

2.9

8.7

54.2

pmol/l

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.68

0.86

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

467

1.24

0.85

1.5

1.2

1.4

1.6

mmol/l

0.76

289

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

807

1.18

0.84

1.2

1.1

—

(3013290) Carbon dioxide [Partial pressure] in Blood

569

5222

1.07

0.84

5.6

4.0

5.1

5.0

kpa

0.98

552

5098

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.78

0.84

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

209

1.36

0.83

1.1

2.2

1.6

umol/24h

2.54

209

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.90

0.82

1.2

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.90

0.82

1.2

1.3

—

(3012501) Base excess in Blood by calculation

568

5221

1.07

0.81

5.6

4.0

2.8

2.6

mmol/l

1.25

410

3615

(3008116) Ketones [Moles/volume] in Urine by Test strip

419

1.24

0.79

1.3

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

161

1.40

0.78

1.3

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

264

1.30

0.76

1.5

1.6

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.61

0.76

1.3

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

121

1.46

0.75

1.2

0.1

g/l

0.55

(40768793) Breast Pathology biopsy report

459

4203

1.07

0.75

1.3

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

317

1.27

0.74

2.4

3.2

34.6

141.9

ng/l

3.24

(3032868) Hemoglobin electrophoresis panel in Blood

122

1.45

0.73

1.9

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

728

0.83

0.72

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

727

0.83

0.72

1.4

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

198

1.34

0.71

2.7

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.96

0.71

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

726

0.84

0.71

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

725

0.84

0.70

1.4

—

(3042517) Benzodiazepines panel - Urine

1.53

0.69

1.1

2.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

107

918

1.14

0.67

5.5

4.8

72.6

469.7

u/ml

0.98

141

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

375

1.23

0.67

2.3

2.9

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

1.58

0.66

1.0

0.1

1.0

u/ml

—

(3016228) CD19 cells/100 cells in Blood

809

1.15

0.66

2.0

1.9

8.4

0.00

784

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.59

0.65

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

473

0.81

0.65

1.5

2.5

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

101

1.45

0.64

1.1

1.4

0.8

1.1

u/field

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

101

1.45

0.64

1.1

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.50

0.63

1.2

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

609

0.84

0.62

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

469

1.19

0.61

1.9

1.8

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

362

1.22

0.61

1.5

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

787

0.86

0.61

1.5

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.60

0.0

1.6

—

17.4

—

(3005033) Fetal Nuchal fold Thickness US

606

0.84

0.59

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

456

0.82

0.59

1.3

1.4

—

(3000012) Reticulocyte production index

124

1354

0.90

0.58

1.4

1.5

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.58

0.0

1.0

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

393

1.20

0.56

1.6

1.3

263.4

152.9

titre

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

1.45

0.56

1.0

0.1

2.8

u/ml

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.50

0.54

27.4

10.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

631

0.85

0.54

1.5

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

132

1168

1.11

0.54

1.0

0.2

0.5

u/ml

0.79

271

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

1.45

0.52

1.0

0.0

0.2

u/ml

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

120

1301

0.90

0.52

1.5

—

(3035933) Granulocytes/100 leukocytes in Blood

353

1.19

0.50

1.2

1.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

136

1211

1.10

0.50

1.4

1.3

70.5

90.5

pmol/l

0.34

400

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.41

0.50

2.4

3.8

—

0.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

785

1.12

0.49

2.0

1.9

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

693

1.13

0.48

1.1

100.6

97.5

0.36

537

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

546

1.15

0.48

2.1

1.6

—

270.2

iu/ml

—

(3044009) aPTT.lupus sensitive (LA screen)

142

1.31

0.48

1.1

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

537

1.15

0.48

1.1

1.0

0.4

1.2

u/ml

0.38

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

239

1.23

0.47

1.5

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

269

2474

1.07

0.46

1.7

1.6

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

240

1.22

0.46

1.5

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

240

1.22

0.46

1.5

1.2

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

1.46

0.45

2.0

2.4

0.1

ug/l

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

206

1.24

0.44

1.2

1.1

12.6

19.3

iu/ml

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

1.42

0.44

1.0

0.0

0.2

u/ml

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

121

1295

0.91

0.43

1.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

300

0.82

0.42

1.5

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.58

0.42

1.0

1.5

2.4

2.2

mmol/24h

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.40

0.42

1.3

1.1

—

mmol/l

—

(3022806) Fractional oxyhemoglobin in Capillary blood

288

2980

0.95

0.41

1.9

1.8

88.6

89.3

1.00

283

2937

(3046861) Legionella sp Ag [Presence] in Urine

136

0.72

0.41

1.0

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

162

1472

1.08

0.41

1.4

1.5

—

(3019174) dRVVT (LA screen)

146

1.27

0.41

1.1

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

180

0.76

0.41

1.3

1.4

—

(3020650) Glucose [Presence] in Urine

435

1.15

0.41

1.3

1.4

—

(3018291) Platelet Ab [Presence] in Serum

1.48

0.40

1.0

1.1

—

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.2

—

678.6

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.40

0.0

2.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

612

0.88

0.40

1.7

1.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

276

0.82

0.40

1.1

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.39

0.0

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

455

1.14

0.39

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.40

0.38

1.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

337

1.16

0.38

1.1

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

453

0.86

0.38

1.4

1.3

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

1.36

0.37

1.0

1.4

22.2

41.6

e6/l

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

477

1.13

0.36

1.1

1.2

—

(40758292) HTLV I+II Ab panel - Serum

283

0.83

0.36

1.4

—

(3027035) Albumin [Mass/time] in 24 hour Urine

203

1.21

0.36

1.3

263.2

380.5

mg/24h

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

143

0.75

0.36

1.0

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.26

0.35

1.4

1.1

0.1

mg/l

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

239

0.82

0.34

1.1

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.37

0.34

1.0

1.1

4.2

2.4

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.34

0.33

1.2

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

144

1507

0.94

0.33

1.0

—

(40767503) Oxygen content in Capillary blood by calculation

524

4964

1.03

0.32

2.9

2.6

15.5

16.2

3.19

301

2571

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.32

0.30

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

168

1554

1.06

0.29

1.2

—

(3045716) Anion gap in Serum or Plasma

116

1060

1.07

0.29

2.5

2.4

8.5

9.1

mmol/l

0.83

795

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

145

1.22

0.29

1.1

1.0

—

(40763590) HLA-DQ beta [Type]

1.22

0.28

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

179

1847

0.95

0.28

1.4

1.5

—

(3003577) Lead [Moles/volume] in Blood

110

1.25

0.27

1.1

1.3

0.1

umol/l

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

116

0.76

0.27

5.6

5.9

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

117

0.75

0.27

2.8

2.9

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.21

0.26

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.28

0.26

1.0

1.1

8.8

8.5

mmol/l

0.30

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

165

1.19

0.26

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

125

0.78

0.26

1.1

2.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

143

1324

1.06

0.26

1.9

1.6

77.2

71.4

umol/l

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

240

1.14

0.24

2.4

3.2

1.1

mg/l

0.10

181

(40763480) Human metapneumovirus Ag [Presence] in Specimen

103

1.24

0.24

1.5

1.4

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

154

0.83

0.22

1.3

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

251

1.13

0.22

2.1

1.5

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.21

0.0

1.1

—

(40768800) Prostate Pathology biopsy report

518

5193

0.98

0.21

1.2

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.20

0.0

1.1

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.20

0.0

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.20

0.0

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

551

0.92

0.20

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

170

1.15

0.20

1.5

2.2

0.6

0.9

mmol/l

0.54

102

(3013637) Mi-2 Ab [Presence] in Serum

509

0.92

0.19

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

509

0.92

0.19

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

509

0.92

0.19

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

509

0.92

0.19

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.13

0.18

1.0

1.2

—

(40760409) HLA-A [Type] by High resolution

1.20

0.18

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.20

0.18

1.0

—

(40760410) HLA-B [Type] by High resolution

1.20

0.18

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

558

5356

1.02

0.18

1.6

1.7

4.1

3.6

mg/l

0.39

432

3844

(3013862) HLA-DP [Type]

1.16

0.17

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

1.14

0.17

1.0

1.1

2.3

1.1

u/field

—

(3029396) Erythrocyte agglutination [Presence] in Blood

126

1.17

0.17

2.2

2.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

191

1.13

0.17

1.0

1.1

—

(4034850)

680

6769

0.98

0.16

13.9

10.8

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.12

0.15

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

150

1512

0.97

0.12

1.7

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

437

0.94

0.12

2.2

1.7

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.16

0.11

11.0

8.7

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

206

1.09

0.11

6.1

5.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

387

1.06

0.11

1.1

—

(40768795) Lymph node Pathology biopsy report

209

2095

0.98

0.11

1.2

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

207

1.09

0.10

1.2

1.1

74.5

62.3

u/ml

0.28

199

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

571

1.05

0.10

1.2

20.5

24.6

0.17

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

112

0.87

0.10

1.5

1.6

22.1

23.8

mmol/l

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.06

0.09

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

104

1.13

0.09

1.8

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.11

0.09

1.2

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

478

1.04

0.08

2.6

2.4

8.0

7.5

mmol/l

0.33

299

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

342

0.94

0.08

1.1

1.2

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.07

0.08

1.2

1.0

0.2

0.3

u/ml

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

126

1204

1.02

0.08

3.9

3.7

—

(3012565) Volume of 24 hour Urine

111

1115

0.97

0.08

2.4

2.1

1856.1

1905.7

0.16

102

963

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.02

0.07

1.0

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

487

4722

1.01

0.07

1.4

1.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.02

0.07

1.7

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

587

0.97

0.06

1.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

382

3701

1.01

0.06

2.0

1.9

1.7

mmol/l

0.13

372

3611

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

545

0.97

0.05

2.5

142.0

148.0

nmol/l

0.09

473

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

242

1.05

0.05

6.1

8.0

0.3

0.4

umol/l

0.42

215

(3039443) Prostate specific Ag panel - Serum or Plasma

348

3376

1.01

0.05

1.6

1.7

—

(3001729) Color of Synovial fluid

187

0.94

0.04

1.4

1.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

408

1.03

0.04

1.1

1.2

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

157

0.94

0.04

1.3

1.5

13.1

42.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

379

1.03

0.04

1.3

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

680

0.98

0.04

2.0

1.9

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

750

1.02

0.03

1.1

32.3

12.3

u/ml

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

274

1.04

0.03

1.8

3.4

39.4

40.0

umol/l

0.05

225

(44806071)

216

1.04

0.03

1.2

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

431

0.98

0.02

4.5

6.0

—

(4133840)

460

0.98

0.02

1.3

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

100

987

0.99

0.01

1.3

1.6

1.5

g/l

0.58

(3034891) Synovial lining cells/100 cells in Synovial fluid

110

1085

0.99

0.01

1.5

1.4

4.9

4.0

0.28

229

(3034092) Cytoplasmic Ig cells/100 cells in Blood

229

1.03

0.00

8.3

10.8

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

151

1.04

0.00

2.8

2.6

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

318

0.99

0.00

1.3

1.4

8.5

8.9

mmol/l

0.25

180

(3050129) First trimester maternal screen panel - Serum or Plasma

897

1.00

0.00

1.5

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

103

1.05

0.00

1.4

1.3

318.5

329.1

umol/24h

0.05

103

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

657

1.00

0.00

1.4

—

(40758358) Immune stain study

1.03

0.00

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

129

0.99

0.00

1.2

1.1

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

0.0

1.0

—

14.3

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

1.6

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

0.0

1.4

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.01

0.00

1.0

1.1

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.0

1.0

—

(3033016) Trichoderma viride IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

0.0

2.8

—

3.4

—

(3029088) Stachybotrys chartarum IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3034610) Cladosporium cladosporioides IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.0

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_COLON and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_COLON	1.273 [1.17, 1.38]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.017

During the follow-up period (1.1.1998 — 31.12.2019), 11356 out of 53486 females with CD2_BENIGN_COLON died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_COLON	1.341 [1.22, 1.47]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 16065 out of 54524 males with CD2_BENIGN_COLON died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_COLON.

N-year risk	Females	Males
1	0.097%	0.274%
5	0.585%	1.585%
10	1.462%	3.781%
15	2.948%	7.304%
20	5.116%	12.564%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_COLON – Benign neoplasm: Colon

GWS hits: 25

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Colon

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints